<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type='text/xsl' href='/w/ProjectMundo-Anon-106A/style/jats-html.xsl'?>
<!DOCTYPE response>
<article article-type="research-article" dtd-version="1.2" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    41467
   </journal-id>
   <journal-id journal-id-type="doi">
    10.1038/41467.2041-1723
   </journal-id>
   <journal-title-group>
    <journal-title>
     Nature Communications
    </journal-title>
    <abbrev-journal-title abbrev-type="publisher">
     Nat Commun
    </abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2041-1723
   </issn>
   <publisher>
    <publisher-name>
     Nature Publishing Group UK
    </publisher-name>
    <publisher-loc>
     London
    </publisher-loc>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">
    s41467-024-46116-y
   </article-id>
   <article-id pub-id-type="manuscript">
    46116
   </article-id>
   <article-id pub-id-type="doi">
    10.1038/s41467-024-46116-y
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Article
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /692/499
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /692/308/575
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /141
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /38/23
     </subject>
    </subj-group>
    <subj-group subj-group-type="NatureArticleTypeID">
     <subject>
      article
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">
     Athari za marekebisho ya microbiome ya utumbo kwenye kazi ya misuli na utambuzi: Jaribio la PROMOTe lililodhibitiwa kwa nasibu
    </article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" corresp="yes" id="Au1">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-5702-1759
     </contrib-id>
     <name name-style="western">
      <surname>
       Ni Lochlainn
      </surname>
      <given-names>
       Mary
      </given-names>
     </name>
     <address>
      <email>
       mary.ni_lochlainn@kcl.ac.uk
      </email>
     </address>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="corresp" rid="IDs4146702446116y_cor1">
      a
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au2">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-6941-8160
     </contrib-id>
     <name name-style="western">
      <surname>
       Bowyer
      </surname>
      <given-names>
       Ruth C. E.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au3">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-3514-4528
     </contrib-id>
     <name name-style="western">
      <surname>
       Moll
      </surname>
      <given-names>
       Janne Marie
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff3">
      3
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au4">
     <name name-style="western">
      <surname>
       García
      </surname>
      <given-names>
       María Paz
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au5">
     <name name-style="western">
      <surname>
       Wadge
      </surname>
      <given-names>
       Samuel
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au6">
     <name name-style="western">
      <surname>
       Baleanu
      </surname>
      <given-names>
       Andrei-Florin
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au7">
     <name name-style="western">
      <surname>
       Nessa
      </surname>
      <given-names>
       Ayrun
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au8">
     <name name-style="western">
      <surname>
       Sheedy
      </surname>
      <given-names>
       Alyce
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au9">
     <name name-style="western">
      <surname>
       Akdag
      </surname>
      <given-names>
       Gulsah
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au10">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-9066-4614
     </contrib-id>
     <name name-style="western">
      <surname>
       Hart
      </surname>
      <given-names>
       Deborah
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au11">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0003-0925-4632
     </contrib-id>
     <name name-style="western">
      <surname>
       Raffaele
      </surname>
      <given-names>
       Giulia
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff4">
      4
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au12">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-7904-7933
     </contrib-id>
     <name name-style="western">
      <surname>
       Seed
      </surname>
      <given-names>
       Paul T.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff5">
      5
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au13">
     <name name-style="western">
      <surname>
       Murphy
      </surname>
      <given-names>
       Caroline
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff6">
      6
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au14">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-8203-0769
     </contrib-id>
     <name name-style="western">
      <surname>
       Harridge
      </surname>
      <given-names>
       Stephen D. R.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff7">
      7
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au15">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-6702-3704
     </contrib-id>
     <name name-style="western">
      <surname>
       Welch
      </surname>
      <given-names>
       Ailsa A.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff8">
      8
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au16">
     <name name-style="western">
      <surname>
       Greig
      </surname>
      <given-names>
       Carolyn
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff9">
      9
     </xref>
     <xref ref-type="aff" rid="Aff10">
      10
     </xref>
     <xref ref-type="aff" rid="Aff11">
      11
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au17">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-5414-2950
     </contrib-id>
     <name name-style="western">
      <surname>
       Whelan
      </surname>
      <given-names>
       Kevin
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff12">
      12
     </xref>
    </contrib>
    <contrib contrib-type="author" corresp="yes" id="Au18">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-4910-0489
     </contrib-id>
     <name name-style="western">
      <surname>
       Steves
      </surname>
      <given-names>
       Claire J.
      </given-names>
     </name>
     <address>
      <email>
       claire.j.steves@kcl.ac.uk
      </email>
     </address>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="corresp" rid="IDs4146702446116y_cor18">
      u
     </xref>
    </contrib>
    <aff id="Aff1">
     <label>
      1
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s College London
      </institution>
      <institution content-type="org-name">
       Department of Twin Research and Genetic Epidemiology
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      SE1 7EH
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff2">
     <label>
      2
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/035dkdb55
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.499548.d
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 5903 3632
      </institution-id>
      <institution content-type="org-name">
       The Alan Turing Institute
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      NW1 2DB
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff3">
     <label>
      3
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/00g934978
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.509919.d
      </institution-id>
      <institution content-type="org-name">
       Clinical Microbiomics
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Copenhagen
     </addr-line>
     <country country="DK">
      Denmark
     </country>
    </aff>
    <aff id="Aff4">
     <label>
      4
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       GKT School of Medical Education
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff5">
     <label>
      5
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       Unit for Medical Statistics/Department for Women and Children’s Health, School of Life Course and Population Sciences, Faculty of Life Sciences and Medicine
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff6">
     <label>
      6
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s Clinical Trials Unit, Research Management and Innovation Directorate
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff7">
     <label>
      7
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       Centre for Human &amp; Applied Physiological Sciences
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff8">
     <label>
      8
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/026k5mg93
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8273.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 1092 7967
      </institution-id>
      <institution content-type="org-division">
       Department of Epidemiology and Public Health, Norwich Medical School
      </institution>
      <institution content-type="org-name">
       University of East Anglia
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      NR4 7TJ
     </addr-line>
     <addr-line content-type="city">
      Norwich
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff9">
     <label>
      9
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/03angcq70
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.6572.6
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 1936 7486
      </institution-id>
      <institution content-type="org-division">
       School of Sport, Exercise, and Rehabilitation Sciences
      </institution>
      <institution content-type="org-name">
       University of Birmingham
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff10">
     <label>
      10
     </label>
     <institution-wrap>
      <institution content-type="org-name">
       MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff11">
     <label>
      11
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/014ja3n03
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.412563.7
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 0376 6589
      </institution-id>
      <institution content-type="org-division">
       NIHR Birmingham Biomedical Research Centre
      </institution>
      <institution content-type="org-name">
       University Hospitals Birmingham NHS Foundation Trust and University of Birmingham
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff12">
     <label>
      12
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s College London, Department of Nutritional Sciences
      </institution>
      <institution content-type="org-name">
       Franklin Wilkins Building
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      SE1 9NH
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
   </contrib-group>
   <author-notes>
    <corresp id="IDs4146702446116y_cor1">
     <label>
      a
     </label>
     <email>
      mary.ni_lochlainn@kcl.ac.uk
     </email>
    </corresp>
    <corresp id="IDs4146702446116y_cor18">
     <label>
      u
     </label>
     <email>
      claire.j.steves@kcl.ac.uk
     </email>
    </corresp>
   </author-notes>
   <pub-date date-type="pub" publication-format="electronic">
    <day>
     29
    </day>
    <month>
     2
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <pub-date date-type="collection" publication-format="electronic">
    <month>
     12
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <volume>
    15
   </volume>
   <issue seq="1859">
    1
   </issue>
   <elocation-id>
    1859
   </elocation-id>
   <history>
    <date date-type="registration">
     <day>
      15
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="received">
     <day>
      4
     </day>
     <month>
      8
     </month>
     <year>
      2023
     </year>
    </date>
    <date date-type="accepted">
     <day>
      12
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="online">
     <day>
      29
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
   </history>
   <pub-history>
    <event event-type="Correction">
     <event-desc>
      A Correction to this paper has been published: https://doi.org/10.1038/s41467-025-58771-w
     </event-desc>
     <date>
      <day>
       10
      </day>
      <month>
       4
      </month>
      <year>
       2025
      </year>
     </date>
    </event>
   </pub-history>
   <permissions>
    <copyright-statement content-type="compact">
     © The Author(s) 2024
    </copyright-statement>
    <copyright-statement content-type="comment">
     corrected publication 2025
    </copyright-statement>
    <copyright-year>
     2024
    </copyright-year>
    <copyright-holder>
     The Author(s)
    </copyright-holder>
    <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
     <license-p>
      <bold>
       Open Access
      </bold>
      This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
      <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">
       http://creativecommons.org/licenses/by/4.0/
      </ext-link>
      .
     </license-p>
    </license>
   </permissions>
   <related-article ext-link-type="doi" related-article-type="correction-forward" xlink:href="10.1038/s41467-025-58771-w"/>
   <abstract id="Abs1" xml:lang="en">
    <title>
     Muhtasari
    </title>
    <p id="Par1">
     Utafiti unapendekeza kwamba kubadilisha microbiota ya utumbo kunaweza kubadilisha fiziolojia ya misuli na tabia ya utambuzi. Microbiota ya utumbo inaweza kuwa na jukumu katika upinzani wa anabolic wa misuli ya wazee, na utambuzi. Katika jaribio hili lililodhibitiwa kwa nasibu, lililofanywa kwa upofu mara mbili na kudhibitiwa na placebo la jozi 36 za mapacha (watu 72), wenye umri wa miaka ≥60, kila jozi ya mapacha ilipangwa kwa nasibu kupokea ama placebo au prebiotic kila siku kwa wiki 12. Mazoezi ya upinzani na nyongeza ya amino asidi za matawi (BCAA) imeagizwa kwa washiriki wote. Matokeo ni kazi ya mwili na utambuzi. Jaribio linafanywa kwa mbali kwa kutumia ziara za video, dodoso za mtandaoni na upimaji wa utambuzi, na kutuma vifaa na sampuli za kibaiolojia. Nyongeza ya prebiotic inavumiliwa vizuri na husababisha mabadiliko katika microbiome ya utumbo [mfano, kuongezeka kwa wingi wa
     <italic>
      Bifidobacterium
     </italic>
     ]. Hakuna tofauti kubwa kati ya prebiotic na placebo kwa matokeo ya msingi ya muda wa kuinuka kwenye kiti (β = 0.579; 95% CI −1.080-2.239 p = 0.494). Prebiotic inaboresha utambuzi (alama ya sababu dhidi ya placebo (β = −0.482; 95% CI,−0.813, −0.141; p = 0.014)). Matokeo yetu yanaonyesha kwamba uingiliaji wa microbiome ya utumbo ambao ni wa bei nafuu na unapatikana kwa urahisi unaweza kuboresha utambuzi katika idadi yetu ya wazee. Tunaonyesha uwezekano wa majaribio yanayotolewa kwa mbali kwa wazee, ambayo yanaweza kupunguza uwakilishi mdogo wa wazee katika majaribio ya kliniki. Usajili wa ClinicalTrials.gov: NCT04309292.
    </p>
   </abstract>
   <abstract abstract-type="ShortSummary" id="Abs2" xml:lang="en">
    <p id="Par2">
     Here, the authors present the results of the PROMOTe trial, reporting improved cognition with prebiotic vs placebo in twins over 60 years old, probing that remote trials are feasible in older adults, and suggesting that the gut microbiota may represent a therapeutic target for age-associated morbidity.
    </p>
   </abstract>
   <kwd-group kwd-group-type="publisher-auto-generated" vocab="springer-nature-taxonomy" xml:lang="en">
    <kwd>
     Microbiome
    </kwd>
    <kwd>
     Nutritional Supplements
    </kwd>
    <kwd>
     Microbiota
    </kwd>
    <kwd>
     Cognitive ageing
    </kwd>
    <kwd>
     Placebo Effect
    </kwd>
    <kwd>
     Preclinical Research
    </kwd>
   </kwd-group>
   <kwd-group kwd-group-type="hierarchical" vocab="FoR" vocab-identifier="ANZSRC 2008">
    <kwd content-type="term" vocab-term-identifier="11">
     Medical and Health Sciences
    </kwd>
    <nested-kwd>
     <kwd content-type="term" vocab-term-identifier="1103">
      Clinical Sciences
     </kwd>
    </nested-kwd>
   </kwd-group>
   <funding-group>
    <award-group>
     <funding-source>
      <institution-wrap>
       <institution>
        DH | National Institute for Health Research (NIHR)
       </institution>
       <institution-id institution-id-type="doi" vocab="open-funder-registry">
        https://doi.org/10.13039/501100000272
       </institution-id>
      </institution-wrap>
     </funding-source>
     <award-id award-type="FundRef grant">
      NIHR300159
     </award-id>
     <principal-award-recipient>
      <name name-style="western">
       <surname>
        Ni Lochlainn
       </surname>
       <given-names>
        Mary
       </given-names>
      </name>
     </principal-award-recipient>
    </award-group>
   </funding-group>
   <custom-meta-group>
    <custom-meta>
     <meta-name>
      publisher-imprint-name
     </meta-name>
     <meta-value>
      Nature Portfolio
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-issue-count
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-article-count
     </meta-name>
     <meta-value>
      10926
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-pricelist-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-holder
     </meta-name>
     <meta-value>
      Springer Nature Limited
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-contains-esm
     </meta-name>
     <meta-value>
      Yes
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-month
     </meta-name>
     <meta-value>
      2
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-day
     </meta-name>
     <meta-value>
      15
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-product
     </meta-name>
     <meta-value>
      NonStandardArchiveJournal
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-grants-type
     </meta-name>
     <meta-value>
      OpenChoice
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      metadata-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      abstract-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodypdf-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodyhtml-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bibliography-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      esm-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      online-first
     </meta-name>
     <meta-value>
      false
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-file-reference
     </meta-name>
     <meta-value>
      BodyRef/PDF/41467_2024_Article_46116.pdf
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-type
     </meta-name>
     <meta-value>
      Typeset
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      target-type
     </meta-name>
     <meta-value>
      OnlinePDF
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-year
     </meta-name>
     <meta-value>
      2025
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-month
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-day
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-type
     </meta-name>
     <meta-value>
      OriginalPaper
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-primary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-collection
     </meta-name>
     <meta-value>
      Science (multidisciplinary)
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      open-access
     </meta-name>
     <meta-value>
      true
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      discipline
     </meta-name>
     <meta-value>
      Humanities and Social Sciences
     </meta-value>
    </custom-meta>
   </custom-meta-group>
  </article-meta>
  <notes notes-type="CrossLinking">
   <sec>
    <p>
     A correction to this article is available online at
     <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-025-58771-w">
      https://doi.org/10.1038/s41467-025-58771-w
     </ext-link>
     .
    </p>
   </sec>
  </notes>
 </front>
 <body>
  <sec id="Sec1" sec-type="introduction">
   <title>
    Utangulizi
   </title>
   <p id="Par3">
    Umri wa wastani wa idadi ya watu unazidi kuongezeka duniani kote. Matokeo yake, kuenea kwa hali zinazohusiana na umri na muda unaotumika kuishi na maradhi yanayohusiana na umri, ikiwa ni pamoja na kupoteza misuli na kupungua kwa utambuzi, vinaongezeka. Kuenea kwa ugonjwa wa akili kunakua duniani kote, lakini kadri idadi ya watu inavyozeeka, utambuzi wa mabadiliko ya utambuzi ambayo yanaweza kutokea kama sehemu ya kuzeeka kwa afya utakuwa muhimu zaidi kwa watafiti na madaktari wanaofanya kazi na wazee. Mazoezi yanaweza kupunguza kupoteza misuli na kupungua kwa utambuzi
    <sup>
     <xref ref-type="bibr" rid="CR1">
      1
     </xref>
     <xref ref-type="bibr" rid="CR2">
      2
     </xref>
     <xref ref-type="bibr" rid="CR3">
      3
     </xref>
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
     ,
     <xref ref-type="bibr" rid="CR5">
      5
     </xref>
    </sup>
    . Kuna sababu nyingi kwa nini wazee wanaweza kupata ugumu wa kufanya mazoezi, ambayo, kutokana na ufanisi wao unaojulikana wa kuboresha afya na utendaji, inatoa changamoto. Hivyo, inahitajika uingiliaji ambao unaonyesha wazi faida mbalimbali za kimwili na kiakili.
   </p>
   <p id="Par4">
    Binadamu hupoteza misuli ya mifupa kadri umri unavyosonga mbele, na hii inaweza kuendelea hadi sarcopenia. Protini ya chakula ni muhimu kwa kudumisha afya ya misuli ya mifupa; hata hivyo, mambo kadhaa yanaweza kusababisha kupungua kwa ulaji wa protini katika umri wa uzee, ikiwa ni pamoja na kutengwa kijamii, dysphagia, na kupungua kwa kasi ya utupu wa tumbo
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
    </sup>
    . Mbali na kula protini kidogo, utafiti umeonyesha kuwa wazee wanaonyesha upinzani wa anabolic kwa ulaji wa protini, mwitikio mdogo wa misuli ya wazee katika suala la usanisi wa protini ya misuli, ikilinganishwa na watu wazima wadogo
    <sup>
     <xref ref-type="bibr" rid="CR7">
      7
     </xref>
    </sup>
    . Hii imesababisha ulaji wa juu wa kila siku wa 1–1.3 g/kg/siku kupendekezwa na wataalamu, ikilinganishwa na Ulaji wa Marejeo wa Virutubisho wa Uingereza kwa watu wazima wa 0.8 g/kg/siku
    <sup>
     <xref ref-type="bibr" rid="CR8">
      8
     </xref>
    </sup>
    .
   </p>
   <p id="Par5">
    Misa ya misuli ya mifupa inadhibitiwa na michakato ya usanisi wa protini ya misuli na kuvunjika (MPS na MPB). Viwango vya MPS vinadhibitiwa kwa kiasi kikubwa na mwitikio kwa vichocheo vya anabolic, ikiwa ni pamoja na ulaji wa chakula na shughuli za kimwili. Vichocheo vya catabolic ni pamoja na ugonjwa, kutofanya mazoezi, na uvimbe, ambapo wazee huwa na viwango vya juu zaidi. Asili ya upinzani wa anabolic ni ngumu, ikihusisha fiziolojia ya kuzeeka na kutofanya mazoezi. Masomo ya nyongeza ya protini kwa utendaji wa misuli yameonyesha matokeo ya kushawishi zaidi wakati yanapounganishwa na mazoezi ya upinzani
    <sup>
     <xref ref-type="bibr" rid="CR8">
      8
     </xref>
    </sup>
    . Mazoezi ya upinzani yameanzishwa vizuri kama kichocheo chenye nguvu cha anabolic kwa misuli ya mifupa, na protini na mazoezi yanaonyesha athari ya ushirikiano yanapotumiwa pamoja
    <sup>
     <xref ref-type="bibr" rid="CR9">
      9
     </xref>
     ,
     <xref ref-type="bibr" rid="CR10">
      10
     </xref>
     ,
     <xref ref-type="bibr" rid="CR11">
      11
     </xref>
    </sup>
    .
   </p>
   <p id="Par6">
    Utafiti wa hivi karibuni unapendekeza kuwa microbiome ya utumbo inaweza kuwa muhimu kwa utendaji wa kiakili na kimwili katika kuzeeka. Microbiome ya utumbo inajumuisha bakteria, archaea, virusi, na vijidudu vya eukaryotic vinavyoishi kwenye utumbo, genome zao za pamoja na mazingira yanayozunguka
    <sup>
     <xref ref-type="bibr" rid="CR12">
      12
     </xref>
    </sup>
    . Jukumu lake katika kudumisha fiziolojia yenye afya ni uwanja unaoendelea haraka wa uchunguzi. Kadri umri unavyoongezeka, uimara wa microbiome ya utumbo unapungua, kwani inakuwa hatarini zaidi kwa magonjwa, dawa, na mabadiliko ya mtindo wa maisha, na mabadiliko ya utajiri wa spishi na kuongezeka kwa utofauti wa watu binafsi
    <sup>
     <xref ref-type="bibr" rid="CR13">
      13
     </xref>
     ,
     <xref ref-type="bibr" rid="CR14">
      14
     </xref>
     ,
     <xref ref-type="bibr" rid="CR15">
      15
     </xref>
     ,
     <xref ref-type="bibr" rid="CR16">
      16
     </xref>
    </sup>
    . Uwezo wa microbiota ya utumbo kubadilisha fiziolojia umeonyeshwa na masomo ya upandikizaji wa kinyesi cha wanyama ambayo yameonyesha mabadiliko ya muundo wa mwili kwa mpokeaji yanayoakisi sifa za mtoaji
    <sup>
     <xref ref-type="bibr" rid="CR17">
      17
     </xref>
    </sup>
    . Hii inaangazia jukumu la microbiota katika kuainisha sifa za kimetaboliki. Mbinu kadhaa zimependekezwa kwa upinzani wa anabolic, na microbiome ya utumbo imetajwa kucheza jukumu katika nyingi ya hizi
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
     ,
     <xref ref-type="bibr" rid="CR18">
      18
     </xref>
     ,
     <xref ref-type="bibr" rid="CR19">
      19
     </xref>
     ,
     <xref ref-type="bibr" rid="CR20">
      20
     </xref>
     ,
     <xref ref-type="bibr" rid="CR21">
      21
     </xref>
    </sup>
    . Mifano ni pamoja na usagaji na unyonyaji wa protini, kazi ya kizuizi cha utumbo, na uvimbe
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
    </sup>
    . Zaidi ya hayo, kuna ushahidi kwamba microbiome ya utumbo inaweza kuathiri misuli ya mifupa kupitia njia za catabolic
    <sup>
     <xref ref-type="bibr" rid="CR22">
      22
     </xref>
     ,
     <xref ref-type="bibr" rid="CR23">
      23
     </xref>
    </sup>
    .
   </p>
   <p id="Par7">
    Prebiotics ni vipengele vya chakula ambavyo hutumiwa kwa kuchagua na microbiome ya utumbo ili kuboresha afya
    <sup>
     <xref ref-type="bibr" rid="CR24">
      24
     </xref>
    </sup>
    . Utawala wa nyongeza ya chakula cha prebiotic umeonyeshwa kuboresha vigezo viwili vya udhaifu wa Fried, yaani nguvu ya mkono na uchovu na kiwango cha jumla cha udhaifu, kwa wazee. Zaidi ya hayo, ushahidi unakua kwa mhimili wa utumbo-ubongo, ikiwa ni pamoja na ushahidi wa awali wa athari nzuri ya nyongeza ya prebiotic kwenye utambuzi
    <sup>
     <xref ref-type="bibr" rid="CR25">
      25
     </xref>
     <xref ref-type="bibr" rid="CR26">
      26
     </xref>
     <xref ref-type="bibr" rid="CR27">
      27
     </xref>
    </sup>
    . Hivyo, microbiota ya utumbo inaweza kuwakilisha lengo la matibabu linaloweza kubadilika kwa ajili ya kuzuia na kubadilisha kupoteza misuli na umri na kupungua kwa utambuzi unaohusiana na umri. Hakuna masomo ya awali ambayo yamechunguza athari za nyongeza inayojumuisha protini na prebiotics kwenye utendaji wa kimwili na kiakili kwa wazee. Mambo ya kijenetiki na mazingira pia yanaathiri utendaji wa kimwili na kiakili, na kupanga kwa nasibu ndani ya jozi za mapacha huondoa utofauti unaotokana na mambo yanayoshirikiwa, kuwezesha utafiti wenye nguvu zaidi. Kwa kadiri tunavyojua, hakuna masomo mengine ambayo yamechunguza athari za nyongeza za protini na prebiotic katika idadi ya mapacha.
   </p>
   <p id="Par8">
    Utafiti huu unalenga kutathmini kama marekebisho ya microbiome ya utumbo kwa kutumia prebiotic inaboresha kazi ya misuli (kama inavyopimwa na muda wa kuinuka mara 5 kutoka kwenye kiti, kipimo cha nguvu ya misuli) dhidi ya placebo katika jaribio ambapo washiriki wote wanapokea protini (matawi ya asidi ya amino [BCAA]) na mazoezi ya upinzani. Utafiti uliundwa ili kujaribu kama kuongeza marekebisho ya microbiome ya utumbo kunaweza kuongeza maboresho ya kazi ya misuli yaliyowekwa kutoka kwa BCAA na mazoezi. Matokeo ya sekondari yalikuwa ni utambuzi, nguvu ya kushika, betri fupi ya utendaji wa mwili, hamu ya kula, na vipimo vya microbiome ya utumbo. Matumizi ya mapacha, ambao wanafanana sana kwa sababu za kijenetiki na mazingira, yaliimarisha muundo wa utafiti.
   </p>
  </sec>
  <sec id="Sec2" sec-type="results">
   <title>
    Matokeo
   </title>
   <p id="Par9">
    Jumla ya watu 626 walikaguliwa kwa kustahiki, ambapo 72 walifanikiwa kuajiriwa (jozi 36 za mapacha). Mchoro
    <xref ref-type="fig" rid="Fig1">
     1
    </xref>
    unaonyesha mtiririko wa washiriki kupitia jaribio. Uajiri ulifunguliwa Mei 2021. Tarehe ya ziara ya kwanza kwa mshiriki wa kwanza ilikuwa 17/05/2021, na tarehe ya ziara ya pili (ya mwisho) ya mshiriki wa mwisho ilikuwa 20/12/2021. Jedwali
    <xref ref-type="table" rid="Tab1">
     1
    </xref>
    lina sifa za msingi za washiriki wa utafiti. Washiriki walikuwa na umri wa wastani wa miaka 73 (kiwango cha 63–83) na walikuwa 78% wanawake (56/72). Mikono ilikuwa imefanana vizuri mwanzoni, kama ilivyotarajiwa, kutokana na muundo wa mapacha. Hata hivyo, kulikuwa na tofauti katika makundi mawili kwa alama ya hamu ya kula ya SNAQ. Kwa hivyo, hii ilijumuishwa katika uchambuzi uliofuata kama kigezo kinachoweza kuchanganya. Hamu ya kula ilijumuishwa katika utafiti kwani tunajua muundo wa microbiome ya utumbo na ulaji wa protini huathiriwa na hamu ya kula
    <sup>
     <xref ref-type="bibr" rid="CR28">
      28
     </xref>
    </sup>
    .
    <fig id="Fig1" position="float">
     <label>
      Fig. 1
     </label>
     <caption xml:lang="en">
      <title>
       Diagramu ya mtiririko wa washiriki.
      </title>
      <p>
       Mtiririko wa washiriki kupitia jaribio, ikiwa ni pamoja na tathmini ya kustahiki, upangaji wa nasibu, ufuatiliaji na uchambuzi.
      </p>
     </caption>
     <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-46116-y/41467_2024_46116_Fig1_HTML.png" mime-subtype="PNG" specific-use="web"/>
    </fig>
    <table-wrap id="Tab1">
     <label>
      Jedwali 1
     </label>
     <caption xml:lang="en">
      <p>
       Sifa za Msingi, kwa mkono wa utafiti
      </p>
     </caption>
     <table frame="hsides" rules="groups">
      <thead>
       <tr>
        <th/>
        <th/>
        <th>
         <p>
          Jumla
         </p>
        </th>
        <th>
         <p>
          Prebiotic
         </p>
        </th>
        <th>
         <p>
          Placebo
         </p>
        </th>
        <th>
         <p>
          <italic>
           p
          </italic>
          -Thamani
         </p>
        </th>
       </tr>
       <tr>
        <th/>
        <th/>
        <th>
         <p>
          <italic>
           N
          </italic>
          = 72
         </p>
        </th>
        <th>
         <p>
          <italic>
           N
          </italic>
          = 36
         </p>
        </th>
        <th>
         <p>
          <italic>
           N
          </italic>
          = 36
         </p>
        </th>
        <th/>
       </tr>
      </thead>
      <tbody>
       <tr>
        <td>
         <p>
          Umri (miaka)
         </p>
        </td>
        <td/>
        <td>
         <p>
          73.1 (4.8)
         </p>
        </td>
        <td>
         <p>
          73.1 (4.9)
         </p>
        </td>
        <td>
         <p>
          73.1 (4.9)
         </p>
        </td>
        <td>
         <p>
          1.000
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Jinsia
         </p>
        </td>
        <td>
         <p>
          Wanawake
         </p>
        </td>
        <td>
         <p>
          56 (77.8%)
         </p>
        </td>
        <td>
         <p>
          28 (77.8%)
         </p>
        </td>
        <td>
         <p>
          28 (77.8%)
         </p>
        </td>
        <td>
         <p>
          1.000
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Wanaume
         </p>
        </td>
        <td>
         <p>
          16 (22.2%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Zygosity
         </p>
        </td>
        <td>
         <p>
          Monozygotic
         </p>
        </td>
        <td>
         <p>
          44 (61.1%)
         </p>
        </td>
        <td>
         <p>
          22 (61.1%)
         </p>
        </td>
        <td>
         <p>
          22 (61.1%)
         </p>
        </td>
        <td>
         <p>
          1.000
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Dizygotic
         </p>
        </td>
        <td>
         <p>
          28 (38.9%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Hali ya Kuvuta Sigara
         </p>
        </td>
        <td>
         <p>
          Hajawahi Kuvuta
         </p>
        </td>
        <td>
         <p>
          38 (52.8%)
         </p>
        </td>
        <td>
         <p>
          19 (52.8%)
         </p>
        </td>
        <td>
         <p>
          19 (52.8%)
         </p>
        </td>
        <td>
         <p>
          0.570
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Aliyewahi Kuvuta
         </p>
        </td>
        <td>
         <p>
          30 (41.7%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          16 (44.4%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Anayevuta Sasa
         </p>
        </td>
        <td>
         <p>
          4 (5.6%)
         </p>
        </td>
        <td>
         <p>
          3 (8.3%)
         </p>
        </td>
        <td>
         <p>
          1 (2.8%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Mapato ya Nyumbani
         </p>
        </td>
        <td>
         <p>
          Alikataa Kujibu
         </p>
        </td>
        <td>
         <p>
          13 (18.1%)
         </p>
        </td>
        <td>
         <p>
          5 (13.9%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td>
         <p>
          0.590
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Mapato ya Chini
         </p>
        </td>
        <td>
         <p>
          30 (41.7%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          16 (44.4%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Mapato ya Kati
         </p>
        </td>
        <td>
         <p>
          23 (31.9%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          9 (25.0%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Mapato ya Juu
         </p>
        </td>
        <td>
         <p>
          6 (8.3%)
         </p>
        </td>
        <td>
         <p>
          3 (8.3%)
         </p>
        </td>
        <td>
         <p>
          3 (8.3%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Kiwango cha Elimu
         </p>
        </td>
        <td>
         <p>
          Chini
         </p>
        </td>
        <td>
         <p>
          33 (45.8%)
         </p>
        </td>
        <td>
         <p>
          18 (50.0%)
         </p>
        </td>
        <td>
         <p>
          15 (41.7%)
         </p>
        </td>
        <td>
         <p>
          0.730
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Kati
         </p>
        </td>
        <td>
         <p>
          25 (34.7%)
         </p>
        </td>
        <td>
         <p>
          11 (30.6%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Juu
         </p>
        </td>
        <td>
         <p>
          14 (19.4%)
         </p>
        </td>
        <td>
         <p>
          7 (19.4%)
         </p>
        </td>
        <td>
         <p>
          7 (19.4%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Matumizi ya Pombe
         </p>
        </td>
        <td>
         <p>
          Hajawahi Kunywa
         </p>
        </td>
        <td>
         <p>
          20 (27.8%)
         </p>
        </td>
        <td>
         <p>
          12 (33.3%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td>
         <p>
          0.510
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Chini ya mara moja kwa wiki
         </p>
        </td>
        <td>
         <p>
          17 (23.6%)
         </p>
        </td>
        <td>
         <p>
          7 (19.4%)
         </p>
        </td>
        <td>
         <p>
          10 (27.8%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Angalau mara moja kwa wiki
         </p>
        </td>
        <td>
         <p>
          35 (48.6%)
         </p>
        </td>
        <td>
         <p>
          17 (47.2%)
         </p>
        </td>
        <td>
         <p>
          18 (50.0%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Uzito (kg)
         </p>
        </td>
        <td/>
        <td>
         <p>
          73.8 (15.7)
         </p>
        </td>
        <td>
         <p>
          71.8 (14.0)
         </p>
        </td>
        <td>
         <p>
          75.8 (17.2)
         </p>
        </td>
        <td>
         <p>
          0.280
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Urefu (m)
         </p>
        </td>
        <td/>
        <td>
         <p>
          1.6 (0.1)
         </p>
        </td>
        <td>
         <p>
          1.6 (0.1)
         </p>
        </td>
        <td>
         <p>
          1.6 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.950
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Kielezo cha Misa ya Mwili
         </p>
        </td>
        <td/>
        <td>
         <p>
          28.0 (5.1)
         </p>
        </td>
        <td>
         <p>
          27.3 (5.0)
         </p>
        </td>
        <td>
         <p>
          28.7 (5.3)
         </p>
        </td>
        <td>
         <p>
          0.240
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Ulaji wa Protini (g/d)
         </p>
        </td>
        <td/>
        <td>
         <p>
          60.7 (14.4)
         </p>
        </td>
        <td>
         <p>
          60.1 (16.2)
         </p>
        </td>
        <td>
         <p>
          61.3 (12.5)
         </p>
        </td>
        <td>
         <p>
          0.710
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Protini/Uzito (g/kg/d)
         </p>
        </td>
        <td/>
        <td>
         <p>
          0.9 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.9 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.8 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.910
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Ulaji wa Nishati (kcals/d)
         </p>
        </td>
        <td/>
        <td>
         <p>
          1569.5 (397.7)
         </p>
        </td>
        <td>
         <p>
          1581.6 (380.5)
         </p>
        </td>
        <td>
         <p>
          1557.5 (419.2)
         </p>
        </td>
        <td>
         <p>
          0.800
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Kielezo cha Udhaifu
         </p>
        </td>
        <td/>
        <td>
         <p>
          0.2 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.2 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.2 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.790
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Kasi ya Kutembea (m/s)
         </p>
        </td>
        <td/>
        <td>
         <p>
          1.1 (0.4)
         </p>
        </td>
        <td>
         <p>
          1.1 (0.4)
         </p>
        </td>
        <td>
         <p>
          1.1 (0.3)
         </p>
        </td>
        <td>
         <p>
          0.640
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Muda wa Kuinuka Kiti (s)
         </p>
        </td>
        <td/>
        <td>
         <p>
          10.6 (3.3)
         </p>
        </td>
        <td>
         <p>
          10.3 (3.2)
         </p>
        </td>
        <td>
         <p>
          11.0 (3.5)
         </p>
        </td>
        <td>
         <p>
          0.370
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Nguvu ya Kushika (kg)
         </p>
        </td>
        <td/>
        <td>
         <p>
          26.0 (9.7)
         </p>
        </td>
        <td>
         <p>
          25.7 (9.5)
         </p>
        </td>
        <td>
         <p>
          26.3 (10.0)
         </p>
        </td>
        <td>
         <p>
          0.800
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Alama ya Mizani
         </p>
        </td>
        <td/>
        <td>
         <p>
          4.0 (0.2)
         </p>
        </td>
        <td>
         <p>
          4.0 (0.0)
         </p>
        </td>
        <td>
         <p>
          3.9 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.160
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Alama ya SPPB
         </p>
        </td>
        <td/>
        <td>
         <p>
          11.0 (1.5)
         </p>
        </td>
        <td>
         <p>
          10.9 (1.5)
         </p>
        </td>
        <td>
         <p>
          11.0 (1.5)
         </p>
        </td>
        <td>
         <p>
          0.810
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          IPAQ MET dakika/wiki
         </p>
        </td>
        <td/>
        <td>
         <p>
          674.8 (654.5)
         </p>
        </td>
        <td>
         <p>
          564.8 (591.2)
         </p>
        </td>
        <td>
         <p>
          784.8 (703.2)
         </p>
        </td>
        <td>
         <p>
          0.160
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Alama ya IPAQ
         </p>
        </td>
        <td>
         <p>
          Shughuli ya Chini
         </p>
        </td>
        <td>
         <p>
          69 (95.8%)
         </p>
        </td>
        <td>
         <p>
          35 (97.2%)
         </p>
        </td>
        <td>
         <p>
          34 (94.4%)
         </p>
        </td>
        <td>
         <p>
          0.560
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Shughuli ya Kati
         </p>
        </td>
        <td>
         <p>
          3 (4.2%)
         </p>
        </td>
        <td>
         <p>
          1 (2.8%)
         </p>
        </td>
        <td>
         <p>
          2 (5.6%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          Hamu ya Kula—SNAQ
         </p>
        </td>
        <td/>
        <td>
         <p>
          15.2 (2.0)
         </p>
        </td>
        <td>
         <p>
          14.7 (2.0)
         </p>
        </td>
        <td>
         <p>
          15.8 (1.9)
         </p>
        </td>
        <td>
         <p>
          0.046*
         </p>
        </td>
       </tr>
       <tr>
        <td colspan="6">
         <p>
          Utambuzi (CANTAB)
         </p>
        </td>
       </tr>
       <tr>
        <td rowspan="2">
         <p>
          Kazi ya Utendaji
         </p>
        </td>
        <td>
         <p>
          OTS—kasi ya wastani (kasi ya majibu; ms)
         </p>
        </td>
        <td>
         <p>
          32773.2 (20028.7)
         </p>
        </td>
        <td>
         <p>
          37476.2 (24711.6)
         </p>
        </td>
        <td>
         <p>
          28766.9 (14250.0)
         </p>
        </td>
        <td>
         <p>
          0.130
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Kumbukumbu ya kufanya kazi ya anga (idadi ya makosa)
         </p>
        </td>
        <td>
         <p>
          14.3 (10.0)
         </p>
        </td>
        <td>
         <p>
          13.0 (8.7)
         </p>
        </td>
        <td>
         <p>
          15.3 (11.0)
         </p>
        </td>
        <td>
         <p>
          0.420
         </p>
        </td>
       </tr>
       <tr>
        <td rowspan="4">
         <p>
          Kumbukumbu
         </p>
        </td>
        <td>
         <p>
          PAL: alama ya kumbukumbu ya jaribio la kwanza
         </p>
        </td>
        <td>
         <p>
          11.9 (4.6)
         </p>
        </td>
        <td>
         <p>
          12.5 (4.5)
         </p>
        </td>
        <td>
         <p>
          11.4 (4.7)
         </p>
        </td>
        <td>
         <p>
          0.430
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          PAL: jumla ya idadi ya makosa
         </p>
        </td>
        <td>
         <p>
          18.0 (16.2)
         </p>
        </td>
        <td>
         <p>
          16.7 (15.9)
         </p>
        </td>
        <td>
         <p>
          19.2 (16.7)
         </p>
        </td>
        <td>
         <p>
          0.580
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Kumbukumbu ya utambuzi wa muundo (% sahihi)
         </p>
        </td>
        <td>
         <p>
          89.5 (10.5)
         </p>
        </td>
        <td>
         <p>
          87.0 (11.7)
         </p>
        </td>
        <td>
         <p>
          91.7 (9.0)
         </p>
        </td>
        <td>
         <p>
          0.110
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          Urefu wa anga (urefu wa mbele; anuwai 2-9)
         </p>
        </td>
        <td>
         <p>
          5.7 (1.3)
         </p>
        </td>
        <td>
         <p>
          5.9 (1.6)
         </p>
        </td>
        <td>
         <p>
          5.5 (1.0)
         </p>
        </td>
        <td>
         <p>
          0.350
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          Takwimu za utambuzi zilizokosekana
         </p>
        </td>
        <td>
         <p>
          22
         </p>
        </td>
        <td>
         <p>
          13
         </p>
        </td>
        <td>
         <p>
          9
         </p>
        </td>
        <td/>
       </tr>
      </tbody>
     </table>
     <table-wrap-foot>
      <p>
       Takwimu endelevu zinawasilishwa kama wastani (upotofu wa kawaida). Takwimu za kategoria zinawasilishwa kama
       <italic>
        n
       </italic>
       (%). * Inaashiria umuhimu. Nambari za data zilizokosekana zimeorodheshwa kwa utambuzi; hakuna vigezo vingine vilivyokosa data.
       <italic>
        P
       </italic>
       thamani ni kulinganisha vikundi kati ya kila mkono wa utafiti uliofanywa kwa kutumia mtihani wa
       <italic>
        t
       </italic>
       wa pande mbili.
      </p>
      <p>
       <italic>
        SPPB
       </italic>
       betri fupi ya utendaji wa mwili,
       <italic>
        IPAQ
       </italic>
       dodoso la kimataifa la shughuli za mwili,
       <italic>
        MET
       </italic>
       sawa ya kimetaboliki ya kazi (MET moja ni nishati unayotumia ukiwa umepumzika),
       <italic>
        SNAQ
       </italic>
       dodoso la tathmini ya lishe rahisi,
       <italic>
        CANTAB
       </italic>
       betri ya mtihani wa kiotomatiki wa neuropsychological wa Cambridge,
       <italic>
        OTS
       </italic>
       mtihani wa utambuzi wa Cambridge wa kugusa moja,
       <italic>
        PAL
       </italic>
       kujifunza kwa washirika wa jozi.
      </p>
     </table-wrap-foot>
    </table-wrap>
   </p>
   <p id="Par10">
    Jedwali la Ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S4
    </xref>
    linaonyesha data ya lishe iliyorekodiwa na washiriki mwanzoni mwa utafiti na mwisho wa utafiti kwa kutumia programu ya mtandaoni ya myfood24. Jedwali la Ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S5
    </xref>
    linaonyesha data hiyo hiyo na waandishi wa habari kupita kiasi kuondolewa kwenye uchambuzi. Hakuna waandishi wa habari chini waligunduliwa. Jedwali la Ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S6
    </xref>
    linaonyesha data ya lishe kwa mkono wa utafiti. Hakukuwa na tofauti kati ya makundi ya prebiotic na placebo mwanzoni au mwisho wa utafiti kwa kipimo chochote cha ulaji wa nyuzi. Kwa ujumla, kulikuwa na upungufu mdogo wa ulaji wa nishati kati ya mwanzo na mwisho wa utafiti, ambao unaonekana kuendeshwa na upungufu katika kundi la prebiotic (−132.4 kcal/d). Tofauti hii ndogo kati ya makundi ya prebiotic na placebo (75.6 kcal/d) iko ndani ya mipaka ya kosa kwa kipimo cha ulaji wa nishati. Athari ya upungufu huu mdogo wa ulaji wa nishati ikijumlishwa kwa muda, ikiwezekana kupitia athari ya inulin kwenye hamu ya kula, inaweza kuchangia athari kwenye nguvu ya misuli. Hata hivyo, tunatambua vikwazo vya kuwa na uwezo wa kupima mabadiliko madogo kama haya katika ulaji wa nishati hata wakati wa kutumia mbinu za kurekodi lishe za kiwango cha juu kwa watu wanaoishi huru. Hakukuwa na tofauti kubwa katika uzito wa mwili (kg) au index ya molekuli ya mwili kati ya mwanzo na mwisho wa utafiti katika mkono wowote (Jedwali la Ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S6
    </xref>
    )
    <sup>
     <xref ref-type="bibr" rid="CR29">
      29
     </xref>
     ,
     <xref ref-type="bibr" rid="CR30">
      30
     </xref>
    </sup>
    .
   </p>
   <p id="Par11">
    Jedwali la Ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S7
    </xref>
    linaonyesha matokeo ya dodoso la tabia ya utumbo, bila tofauti zilizopatikana kati ya makundi ya uingiliaji kwa swali lolote linalohusiana na tabia za utumbo. Jedwali la Ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S1
    </xref>
    linaonyesha sifa za kidemografia za wale ambao hawakustahiki au walikataa kushiriki dhidi ya wale waliochukua sehemu, kwa kutumia data ya muda mrefu ya TwinsUK iliyopo. Kikundi ni wanawake wengi kwa sababu za kihistoria. Washiriki walikuwa vijana zaidi na kulikuwa na wanaume zaidi kuliko kikundi kikubwa cha TwinsUK. Tofauti kubwa ilibaki baada ya kurekebisha tofauti ya jinsia kwa umri na tofauti ya umri kwa jinsia (Jedwali la Ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     S1
    </xref>
    ).
   </p>
   <sec id="Sec3">
    <title>
     Matukio mabaya na utii
    </title>
    <p id="Par12">
     Kulikuwa na ziada ya matukio mabaya madogo (kama vile kuvimba kwa tumbo) katika mkono wa prebiotic kuliko mkono wa placebo, lakini hakuna tofauti katika utii, ikionyesha kwamba virutubisho kwa ujumla vilivumiliwa vizuri. Hakuna mshiriki aliyeripoti 'athari ya upande wa utumbo' kama sababu ya kutokufuata uingiliaji wa utafiti katika mkono wowote. Hakuna matukio mabaya makubwa yaliyotokea.
    </p>
    <p id="Par13">
     Jedwali
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     linafupisha idadi ya matukio mabaya kwa kila mkono na ufuasi wa uingiliaji. Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      S2
     </xref>
     linaorodhesha matukio yote mabaya yaliyoripotiwa na washiriki. Pia tulirekodi mabadiliko ya dawa (Jedwali
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     ) wakati wa utafiti, ambayo yalikuwa machache.
     <table-wrap id="Tab2">
      <label>
       Jedwali 2
      </label>
      <caption xml:lang="en">
       <p>
        Matukio mabaya ya PROMOTe, mabadiliko ya dawa, kufuata, na kuacha kwa mkono wa utafiti
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th/>
         <th>
          <p>
           Jumla
          </p>
         </th>
         <th>
          <p>
           Mkono wa Prebiotic
          </p>
         </th>
         <th>
          <p>
           Mkono wa Placebo
          </p>
         </th>
         <th>
          <p>
           <italic>
            p
           </italic>
           -Thamani
          </p>
         </th>
        </tr>
        <tr>
         <th/>
         <th>
          <p>
           <italic>
            N
           </italic>
           = 72
          </p>
         </th>
         <th>
          <p>
           <italic>
            N
           </italic>
           = 36
          </p>
         </th>
         <th>
          <p>
           <italic>
            N
           </italic>
           = 36
          </p>
         </th>
         <th/>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td>
          <p>
           Walioacha utafiti
           <italic>
            n
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           4 (6%)
          </p>
         </td>
         <td>
          <p>
           2 (6%)
          </p>
         </td>
         <td>
          <p>
           2 (6%)
          </p>
         </td>
         <td>
          <p>
           1
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Tukio baya
           <italic>
            n
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           10 (7%)
          </p>
         </td>
         <td>
          <p>
           8 (22%)
          </p>
         </td>
         <td>
          <p>
           2 (6%)
          </p>
         </td>
         <td>
          <p>
           0.041*
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko ya dawa
           <italic>
            n
           </italic>
           /
           <italic>
            N
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           7/60 (12%)
          </p>
         </td>
         <td>
          <p>
           2/29 (7%)
          </p>
         </td>
         <td>
          <p>
           5/31 (16%)
          </p>
         </td>
         <td>
          <p>
           0.270
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           <italic>
            Kufuata
           </italic>
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mazoezi
           <italic>
            n
           </italic>
           /
           <italic>
            N
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           59/59 (100%)
          </p>
         </td>
         <td>
          <p>
           30/30 (100%)
          </p>
         </td>
         <td>
          <p>
           28/29 (97%)
          </p>
         </td>
         <td>
          <p>
           –
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Vifurushi
           <italic>
            n
           </italic>
           /
           <italic>
            N
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           59/59 (100%)
          </p>
         </td>
         <td>
          <p>
           30/30 (100%)
          </p>
         </td>
         <td>
          <p>
           29/29 (100%)
          </p>
         </td>
         <td>
          <p>
           –
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Hesabu ya vifurushi, % kufuata wastani (SD)
          </p>
         </td>
         <td>
          <p>
           78.7% (9.6)
          </p>
         </td>
         <td>
          <p>
           79.7% (10.5)
          </p>
         </td>
         <td>
          <p>
           77.5% (8.6)
          </p>
         </td>
         <td>
          <p>
           0.370
          </p>
         </td>
        </tr>
       </tbody>
      </table>
      <table-wrap-foot>
       <p>
        Takwimu zinawasilishwa kama
        <italic>
         n
        </italic>
        (%). Kwa data yenye data isiyokamilika, data hizi zinawasilishwa kama
        <italic>
         n
        </italic>
        /
        <italic>
         N
        </italic>
        (%).
        <italic>
         P
        </italic>
        thamani ni kulinganisha vikundi kati ya kila mkono wa utafiti uliofanywa kwa kutumia mtihani wa
        <italic>
         t
        </italic>
        wa pande mbili. *inaashiria umuhimu wa takwimu.
       </p>
      </table-wrap-foot>
     </table-wrap>
    </p>
   </sec>
   <sec id="Sec4">
    <title>
     Matokeo ya msingi na ya sekondari
    </title>
    <p id="Par14">
     Matokeo ya mifano mchanganyiko ya mstari kwa matokeo ya msingi na ya sekondari yanaonyeshwa katika Jedwali
     <xref ref-type="table" rid="Tab3">
      3
     </xref>
     , ikijumuisha uchambuzi wa nia ya kutibu (ITT) na kwa itifaki (PP). Hakukuwa na tofauti kubwa katika matokeo kati ya mifano ya ITT na PP. Hakukuwa na tofauti kati ya prebiotic na placebo kwa matokeo ya msingi ya muda wa kuinuka kwenye kiti (mabadiliko ya wastani kati ya mwanzo na mwisho wa utafiti 0.88 s [SD 2.16] kwa prebiotic na 1.12 s [SD 1.52] kwa placebo;
     <italic>
      p
     </italic>
     = 0.631), wala kwa matokeo ya sekondari ya utendaji wa mwili (nguvu ya mkono, betri fupi ya utendaji wa mwili, na dakika za IPAQ MET) au alama ya hamu ya SNAQ.
     <table-wrap id="Tab3">
      <label>
       Jedwali 3
      </label>
      <caption xml:lang="en">
       <p>
        Matokeo ya modeli ya athari mchanganyiko ya mstari kwa matokeo ya msingi na ya sekondari
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th colspan="2">
          <p>
           Matokeo
          </p>
         </th>
         <th>
          <p>
           Prebiotic
          </p>
         </th>
         <th>
          <p>
           Placebo
          </p>
         </th>
         <th colspan="6">
          <p>
           Athari ya matibabu (prebiotic = kikundi cha kumbukumbu)
          </p>
         </th>
        </tr>
        <tr>
         <th colspan="2"/>
         <th/>
         <th/>
         <th colspan="3">
          <p>
           Kusudia kutibu
          </p>
         </th>
         <th colspan="3">
          <p>
           Kulingana na itifaki
          </p>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td colspan="2">
          <p>
           <italic>
            Matokeo ya msingi
           </italic>
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           Mgawo
          </p>
         </td>
         <td>
          <p>
           95% CI
          </p>
         </td>
         <td>
          <p>
           <italic>
            P
           </italic>
           -thamani
          </p>
         </td>
         <td>
          <p>
           Mgawo
          </p>
         </td>
         <td>
          <p>
           95% CI
          </p>
         </td>
         <td>
          <p>
           <italic>
            P
           </italic>
           -thamani
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Muda wa Kuinuka Kiti (sekunde)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           0.58
          </p>
         </td>
         <td>
          <p>
           1.08,2.24
          </p>
         </td>
         <td>
          <p>
           0.494
          </p>
         </td>
         <td>
          <p>
           0.58
          </p>
         </td>
         <td>
          <p>
           1.08,2.24
          </p>
         </td>
         <td>
          <p>
           0.494
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           10.38 (3.21)
          </p>
         </td>
         <td>
          <p>
           10.24 (2.21)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           9.49 (2.89)
          </p>
         </td>
         <td>
          <p>
           9.12 (1.96)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           0.88 (2.16)
          </p>
         </td>
         <td>
          <p>
           1.12 (1.52)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           <italic>
            Matokeo ya sekondari
           </italic>
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Nguvu ya Kushika (kg)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           1.22
          </p>
         </td>
         <td>
          <p>
           −2.43,4.86
          </p>
         </td>
         <td>
          <p>
           0.512
          </p>
         </td>
         <td>
          <p>
           1.22
          </p>
         </td>
         <td>
          <p>
           −2.43,4.86
          </p>
         </td>
         <td>
          <p>
           0.512
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           26.23 (9.33)
          </p>
         </td>
         <td>
          <p>
           25.52 (9.27)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           28.98 (11.64)
          </p>
         </td>
         <td>
          <p>
           29.14 (10.08)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           2.74 (10.76)
          </p>
         </td>
         <td>
          <p>
           3.45 (8.48)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Alama ya SPPB (anuwai 0-12)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −0.13
          </p>
         </td>
         <td>
          <p>
           −0.56,0.30
          </p>
         </td>
         <td>
          <p>
           0.551
          </p>
         </td>
         <td>
          <p>
           −0.13
          </p>
         </td>
         <td>
          <p>
           −0.56,0.30
          </p>
         </td>
         <td>
          <p>
           0.551
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           10.88 (1.49)
          </p>
         </td>
         <td>
          <p>
           11.32 (1.05)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           11.12 (1.32)
          </p>
         </td>
         <td>
          <p>
           11.45 (0.81)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           0.24 (1.05)
          </p>
         </td>
         <td>
          <p>
           0.06 (1.01)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           IPAQ MET dakika
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           194.43
          </p>
         </td>
         <td>
          <p>
           −111.39, 500.24
          </p>
         </td>
         <td>
          <p>
           0.213
          </p>
         </td>
         <td>
          <p>
           245.18
          </p>
         </td>
         <td>
          <p>
           −70.36, 560.73
          </p>
         </td>
         <td>
          <p>
           0.128
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           538.09 (596.87)
          </p>
         </td>
         <td>
          <p>
           769.30 (640.08)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           771.09 (594.28)
          </p>
         </td>
         <td>
          <p>
           1030.83 (648.33)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           256.06 (853.84)
          </p>
         </td>
         <td>
          <p>
           72.04 (866.41)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Hamu ya Kula (SNAQ) (anuwai 4-20)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           0.19
          </p>
         </td>
         <td>
          <p>
           −0.54,0.92
          </p>
         </td>
         <td>
          <p>
           0.607
          </p>
         </td>
         <td>
          <p>
           0.24
          </p>
         </td>
         <td>
          <p>
           −0.51,0.99
          </p>
         </td>
         <td>
          <p>
           0.532
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           14.79 (1.79)
          </p>
         </td>
         <td>
          <p>
           15.89 (1.76)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           14.71 (1.88)
          </p>
         </td>
         <td>
          <p>
           15.80 (2.00)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           −0.01 (1.29)
          </p>
         </td>
         <td>
          <p>
           −0.01 (1.62)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td rowspan="4">
          <p>
           Utambuzi (CANTAB)
          </p>
         </td>
         <td>
          <p>
           Alama ya sababu ya utambuzi
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −0.48
          </p>
         </td>
         <td>
          <p>
           −0.81, −0.14
          </p>
         </td>
         <td>
          <p>
           0.014*
          </p>
         </td>
         <td>
          <p>
           −0.48
          </p>
         </td>
         <td>
          <p>
           −0.81, −0.14
          </p>
         </td>
         <td>
          <p>
           0.014*
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           0.05 (1.00)
          </p>
         </td>
         <td>
          <p>
           −0.23 (0.94)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           0.59 (0.68)
          </p>
         </td>
         <td>
          <p>
           0.18 (0.60)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           0.40 (0.83)
          </p>
         </td>
         <td>
          <p>
           0.19 (0.70)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td rowspan="8">
          <p>
           Kazi ya Utendaji
          </p>
         </td>
         <td>
          <p>
           OTS—kasi ya wastani (kasi ya majibu; ms)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           631.22
          </p>
         </td>
         <td>
          <p>
           −8910.33, 10171.76
          </p>
         </td>
         <td>
          <p>
           0.889
          </p>
         </td>
         <td>
          <p>
           631.22
          </p>
         </td>
         <td>
          <p>
           −8910.33, 10171.76
          </p>
         </td>
         <td>
          <p>
           0.889
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           37,837.29 (25230.98)
          </p>
         </td>
         <td>
          <p>
           28,318.90 (14707.45)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           32,737.31 (21417.24)
          </p>
         </td>
         <td>
          <p>
           26,555.30 (13306.24)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           −1.0e + 04 (13,978.77)
          </p>
         </td>
         <td>
          <p>
           −6594.90 (9405.05)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Kumbukumbu ya kufanya kazi ya anga (idadi ya makosa)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −1.84
          </p>
         </td>
         <td>
          <p>
           −7.12,3.43
          </p>
         </td>
         <td>
          <p>
           0.457
          </p>
         </td>
         <td>
          <p>
           −1.84
          </p>
         </td>
         <td>
          <p>
           −7.12,3.43
          </p>
         </td>
         <td>
          <p>
           0.457
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           12.77 (8.89)
          </p>
         </td>
         <td>
          <p>
           15.13 (11.52)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           10.15 (6.39)
          </p>
         </td>
         <td>
          <p>
           11.23 (9.16)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           −3.08 (9.22)
          </p>
         </td>
         <td>
          <p>
           −5.46 (10.44)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td rowspan="16">
          <p>
           Kumbukumbu
          </p>
         </td>
         <td>
          <p>
           PAL: alama ya kumbukumbu ya jaribio la kwanza
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −1.95
          </p>
         </td>
         <td>
          <p>
           −4.43,0.52
          </p>
         </td>
         <td>
          <p>
           0.104
          </p>
         </td>
         <td>
          <p>
           −1.95
          </p>
         </td>
         <td>
          <p>
           −4.43,0.52
          </p>
         </td>
         <td>
          <p>
           0.104
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           12.41 (4.64)
          </p>
         </td>
         <td>
          <p>
           10.88 (4.44)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           14.54 (3.99)
          </p>
         </td>
         <td>
          <p>
           12.69 (3.38)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           1.77 (4.53)
          </p>
         </td>
         <td>
          <p>
           0.77 (4.19)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           PAL: jumla ya idadi ya makosa
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           7.55
          </p>
         </td>
         <td>
          <p>
           4.65, 10.46
          </p>
         </td>
         <td>
          <p>
           0.001*
          </p>
         </td>
         <td>
          <p>
           7.55
          </p>
         </td>
         <td>
          <p>
           4.65, 10.46
          </p>
         </td>
         <td>
          <p>
           0.001*
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           17.05 (16.13)
          </p>
         </td>
         <td>
          <p>
           20.67 (17.05)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           9.15 (7.05)
          </p>
         </td>
         <td>
          <p>
           12.23 (10.15)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           −5.15 (13.92)
          </p>
         </td>
         <td>
          <p>
           −5.00 (12.34)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Kumbukumbu ya utambuzi wa muundo (% sahihi)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −3.00
          </p>
         </td>
         <td>
          <p>
           −9.40,3.40
          </p>
         </td>
         <td>
          <p>
           0.331
          </p>
         </td>
         <td>
          <p>
           −3.00
          </p>
         </td>
         <td>
          <p>
           −9.40,3.40
          </p>
         </td>
         <td>
          <p>
           0.331
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           86.74 (11.97)
          </p>
         </td>
         <td>
          <p>
           91.32 (9.35)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           97.44 (7.12)
          </p>
         </td>
         <td>
          <p>
           93.59 (7.72)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           8.33 (7.61)
          </p>
         </td>
         <td>
          <p>
           1.92 (9.71)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Urefu wa anga (urefu wa mbele; anuwai 2–9)
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −0.86
          </p>
         </td>
         <td>
          <p>
           −1.97,0.26
          </p>
         </td>
         <td>
          <p>
           0.120
          </p>
         </td>
         <td>
          <p>
           −0.86
          </p>
         </td>
         <td>
          <p>
           −1.97,0.26
          </p>
         </td>
         <td>
          <p>
           0.120
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Msingi
          </p>
         </td>
         <td>
          <p>
           5.91 (1.63)
          </p>
         </td>
         <td>
          <p>
           5.50 (1.06)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mwisho wa Utafiti
          </p>
         </td>
         <td>
          <p>
           6.69 (1.60)
          </p>
         </td>
         <td>
          <p>
           5.46 (0.66)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko kati ya msingi na mwisho wa utafiti
          </p>
         </td>
         <td>
          <p>
           0.54 (1.56)
          </p>
         </td>
         <td>
          <p>
           −0.23 (1.09)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
       </tbody>
      </table>
      <table-wrap-foot>
       <p>
        Kikundi cha prebiotic = kikundi cha kumbukumbu * Inaashiria umuhimu.
       </p>
       <p>
        Takwimu endelevu zinawasilishwa kama wastani (upotofu wa kawaida), na kategoria zinawasilishwa kama
        <italic>
         n
        </italic>
        (%). Miundo yote ya mstari mchanganyiko imerekebishwa kwa alama ya SNAQ katika msingi.
       </p>
       <p>
        <italic>
         CI
        </italic>
        muda wa kujiamini,
        <italic>
         SPPB
        </italic>
        betri fupi ya utendaji wa mwili,
        <italic>
         IPAQ
        </italic>
        dodoso la kimataifa la shughuli za mwili,
        <italic>
         MET
        </italic>
        sawa ya kimetaboliki ya kazi (MET moja ni nishati unayotumia ukiwa umepumzika),
        <italic>
         SNAQ
        </italic>
        dodoso la tathmini ya lishe rahisi,
        <italic>
         CANTAB
        </italic>
        betri ya mtihani wa kiotomatiki wa neuropsychological wa Cambridge,
        <italic>
         OTS
        </italic>
        mtihani wa utambuzi wa Cambridge wa kugusa moja,
        <italic>
         PAL
        </italic>
        kujifunza kwa washirika wa jozi.
       </p>
      </table-wrap-foot>
     </table-wrap>
    </p>
    <p id="Par15">
     Kikundi cha prebiotic kilionyesha uboreshaji mkubwa katika alama ya sababu ya kwanza ya utambuzi ikilinganishwa na placebo (
     <italic>
      β
     </italic>
     = −0.482; 95% CI −0.813, −0.141;
     <italic>
      p
     </italic>
     = 0.014). Aidha, jaribio maalum la utambuzi la kujifunza kwa washirika (jaribio la kumbukumbu) lilikuwa na idadi ndogo ya makosa katika kikundi cha prebiotic ikilinganishwa na placebo (
     <italic>
      β
     </italic>
     = 7.55; 95% CI: 4.65–10.46;
     <italic>
      p
     </italic>
     = 0.001). Jaribio hili maalum la utambuzi lina umuhimu wa kliniki, likiwa limetambuliwa kama kitambulisho cha mapema cha ugonjwa wa akili wa Alzheimer
     <sup>
      <xref ref-type="bibr" rid="CR31">
       31
      </xref>
      ,
      <xref ref-type="bibr" rid="CR32">
       32
      </xref>
     </sup>
     . Upungufu wa data ulikuwa juu zaidi kwa majaribio ya utambuzi ya CANTAB ikilinganishwa na vigezo vingine vya matokeo. Hakukuwa na tofauti kubwa zilipopimwa vipengele vya kidemografia vya wale waliokamilisha majaribio ya utambuzi dhidi ya wale ambao hawakufanya hivyo, hivyo hakuna vipengele maalum vilivyotabiri upungufu wa majaribio ya utambuzi, kama inavyoonyeshwa katika Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      S3
     </xref>
     <sup/>
     . Hakuna uchambuzi wa baada ya tukio usiopangwa uliofanywa.
    </p>
   </sec>
   <sec id="Sec5">
    <title>
     Matokeo ya microbiome ya utumbo
    </title>
    <p id="Par16">
     Mbali na matokeo ya sekondari ya utendaji wa mwili, muundo na utendaji wa microbiome ya utumbo vilichambuliwa na kupatikana kutoka kwa sampuli za kinyesi. Data nzuri ya mpangilio ilipatikana kutoka kwa sampuli zote, na wastani wa jozi za kusoma 21.6 M kwa sampuli na kiwango cha chini cha jozi za kusoma 11.7 M. (Mchoro wa Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      S1
     </xref>
     ). Kwa wastani, jozi za kusoma 17.9 M kwa sampuli zingeweza kuorodheshwa kwenye orodha ya jeni, ikiwakilisha wastani wa 82.8% ya usomaji wa HQNH (min = 68.5%, angalia Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      S8
     </xref>
     ), ikiwakilisha MGS 1494. Sampuli nyingi zilitawaliwa na familia
     <italic>
      Bacteroidaceae
     </italic>
     ,
     <italic>
      Oscillospiraceae
     </italic>
     , na
     <italic>
      Lachnospiraceae
     </italic>
     , na tofauti fulani kati ya watu binafsi, kama inavyotarajiwa.
    </p>
    <sec id="Sec6">
     <title>
      Ulinganifu wa microbiota ya pacha
     </title>
     <p id="Par17">
      Ulinganifu kati ya muundo wa microbiota ya mapacha wa utafiti mwanzoni na mwisho wa utafiti ulichunguzwa, na uchambuzi wa urithi ulifanywa (Mchoro wa Ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S2
      </xref>
      ). Ingawa kulikuwa na ushahidi wa tofauti za ndani ya jozi za mapacha katika muundo wa microbiota (Mchoro wa Ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S3
      </xref>
      ), tuligundua kuwa microbiota ya mapacha ilikuwa sawa zaidi ikilinganishwa na muundo wa microbiota wa watu wasiohusiana wote mwanzoni (
      <italic>
       U
      </italic>
      = 55579,
      <italic>
       p
      </italic>
      = 0.0026) na mwisho wa utafiti (
      <italic>
       U
      </italic>
      = 44342,
      <italic>
       p
      </italic>
      = 0.00072), kwa kutumia tofauti ya Bray–Curtis (Mchoro wa Ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S4
      </xref>
      ).
     </p>
     <p id="Par18">
      Ingawa thamani za p za mtihani wa Mann–Whitney
      <italic>
       U
      </italic>
      zinazolinganishwa kati ya mapacha na wasio mapacha ni muhimu katika vipindi vyote viwili, uchambuzi wa ziada wa takwimu ulifanywa ili kuthibitisha kwamba matokeo haya hayakusababishwa na idadi kubwa ya uchunguzi wa jozi katika kundi la wasio mapacha. Kwa kulinganisha jozi 35 za mapacha, kuna uchunguzi mwingi zaidi wa kulinganisha wasio mapacha wawili (35 * (35 − 1)/2 = uchunguzi 595) kuliko mapacha wawili (uchunguzi 35), jambo ambalo linadhoofisha uhalali wa kulinganisha rahisi kwa makundi mawili kutokana na idadi kubwa ya uchunguzi katika kundi la wasio mapacha. Kwa hiyo, mbinu ya kubadilisha ilitumika kutathmini kama takwimu ya mtihani iliyopatikana kwa kulinganisha makundi ilikuwa tofauti kwa kiasi kikubwa na usambazaji wa takwimu ya mtihani iliyopatikana kwa kubadilisha kwa nasibu lebo za uchunguzi (Supplementary Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S5
      </xref>
      ). Kwa msingi na mwisho wa utafiti, thamani ya
      <italic>
       p
      </italic>
      ya kulinganisha kati ya takwimu ya mtihani halisi na usambazaji wa takwimu ya mtihani iliyopatikana kutoka kwa mabadiliko ilikuwa karibu na sifuri (Mann–Whitney
      <italic>
       U
      </italic>
      test,
      <italic>
       P
      </italic>
      = 3.33 * 10 na 3.33 * 10, kwa msingi na mwisho wa utafiti, mtawalia), ikionyesha kuwa muundo wa microbiota ni sawa zaidi ndani ya jozi za mapacha kuliko kati ya watu wawili kutoka jozi tofauti za mapacha
      <sup/>
      .
     </p>
    </sec>
    <sec id="Sec7">
     <title>
      Microbiota kati ya prebiotic na placebo
     </title>
     <p id="Par19">
      Hakuna sifa za microbiota zilizokuwa tofauti kwa kiasi kikubwa kati ya prebiotic na placebo mwanzoni kama ilivyotathminiwa na PERMANOVA. Mchoro
      <xref ref-type="fig" rid="Fig2">
       2
      </xref>
      unaonyesha kulinganisha kati ya makundi mwishoni mwa utafiti, ukionyesha tofauti 11 muhimu, nyingi zikisababishwa na wingi wa jamaa wa
      <italic>
       Bifidobacterium
      </italic>
      katika kundi la prebiotic, ikijumuisha wingi zaidi kutoka ngazi ya phylum ya Actinobacteria hadi ngazi ya jenasi, ongezeko dogo katika phyla Firmicutes na Bacteroidetes, na kupungua kwa spishi
      <italic>
       Phocea massiliensis
      </italic>
      na jenasi yake inayohusiana. Aidha, Mchoro
      <xref ref-type="fig" rid="Fig2">
       2
      </xref>
      unaonyesha sifa kumi na tano za microbiota zilizopatikana kuwa tofauti kwa kiasi kikubwa kati ya makundi ya prebiotic na placebo wakati wa kulinganisha wingi wa jamaa mwishoni mwa utafiti uliorekebishwa kwa wingi wa msingi na jozi za mapacha. Mbali na athari kuu za kuongezeka kwa Bifidobacterium na kupungua kwa
      <italic>
       P. massiliensis
      </italic>
      zilizozingatiwa kwa uchambuzi wa msalaba, kundi la prebiotic lina wingi wa chini wa jamaa wa
      <italic>
       Anaeromassilibacillus
      </italic>
      na uteuzi wa taxonomies za ngazi ya juu, kama vile Deltaproteobacteria, Lactobacillales, na Eubacteriales.
      <fig id="Fig2" position="float">
       <label>
        Fig. 2
       </label>
       <caption xml:lang="en">
        <title>
         Ulinganisho wa vikundi vya mapacha kati ya virutubisho vya prebiotic na placebo, ikiwa ni pamoja na data kutoka mwisho wa utafiti au tofauti kati ya mwanzo na mwisho wa utafiti.
        </title>
        <p>
         Ulinganisho wa vikundi vilivyopangwa wa wingi wa jamaa (a) na uwepo (p) wa aina za bakteria kati ya mikono ya utafiti kwa mtazamo wa msalaba au mwisho wa utafiti uliorekebishwa kwa wingi wa aina za mwanzo. Upimaji wa tofauti katika wingi wa aina za microbiome ulifanywa kwa mfumo wa usawa wa mstari na marekebisho ya upendeleo wa muundo kulingana na LinDA. Hakukuwa na tofauti kubwa kati ya vikundi mwanzoni au kwa moduli za kimetaboliki ya utumbo, moduli za utumbo-ubongo, au utofauti wa alpha. Ukubwa wa athari ni vipeo vilivyorekebishwa kwa upendeleo kutoka kwa mifano ya mstari ambapo ukubwa wa athari chanya (bluu) unaonyesha viwango vya juu katika kundi la placebo na ukubwa wa athari hasi (nyekundu) unaonyesha viwango vya juu katika kundi la prebiotic.
        </p>
       </caption>
       <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-46116-y/41467_2024_46116_Fig2_HTML.png" mime-subtype="PNG" specific-use="web"/>
      </fig>
     </p>
     <p id="Par20">
      Hakukuwa na tofauti kubwa kati ya makundi ya prebiotic na placebo kwa kipimo chochote cha utofauti wa alpha. Pia hakukuwa na tofauti kubwa katika utofauti wa beta kati ya makundi ya prebiotic na placebo mwishoni mwa utafiti kama ilivyotathminiwa na PERMANOVA. Tofauti ya ndani ya jozi kwa utofauti wa beta haikupatikana kuwa juu mwishoni mwa utafiti kuliko mwanzoni mwa utafiti (
      <italic>
       V
      </italic>
      = 102;
      <italic>
       p
      </italic>
      = 0.58). Mchoro wa ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S7
      </xref>
      unaonyesha kulinganisha kwa Bray–Curtis dissimilarity kati ya jozi za mapacha, ikijumuisha kugawanya kwa zygosity.
     </p>
     <p id="Par21">
      Wakati wa kufanya kulinganisha ndani ya kundi kati ya msingi na mwisho wa utafiti, kulikuwa na sifa 40 tofauti kwa kiasi kikubwa wakati wa kulinganisha sampuli kutoka mkono wa prebiotic wakati tu wingi wa jamaa wa
      <italic>
       Actinomyces graevenitzii
      </italic>
      ulikuwa tofauti kwa kiasi kikubwa wakati wa kulinganisha sampuli kutoka mkono wa placebo (Mchoro wa ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S6
      </xref>
      ).
     </p>
    </sec>
    <sec id="Sec8">
     <title>
      Sifa za microbiota na nguvu za misuli
     </title>
     <p id="Par22">
      Katika mfano wa mstari uliorekebishwa kwa upendeleo wa muundo unaorekebisha kwa athari zinazohusiana na mkono na jozi za mapacha, sifa 129 za microbiota zilihusishwa kwa kiasi kikubwa na muda wa kuinuka kwenye kiti, ikijumuisha taxa 95 za vijidudu, kazi 32 za vijidudu, na utajiri na utofauti wa phylogenetic wa Faith (Mchoro wa ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S8
      </xref>
      ). Uchambuzi wa uhusiano (mgawo wa uhusiano wa Pearson kutoka kwa mifano inayotumia wingi uliobadilishwa wa log-ratio) kati ya mabadiliko katika muda wa kuinuka kwenye kiti na mabadiliko katika sifa za microbiota katika kipindi cha uingiliaji wa utafiti (kuchambua washiriki wote pamoja), ulionyesha uhusiano kati ya kuboreshwa kwa muda wa kuinuka kwenye kiti na mabadiliko katika utajiri (
      <italic>
       r
      </italic>
      = −0.347;
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0159), utofauti wa Shannon (
      <italic>
       r
      </italic>
      = −0.250;
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0486), na utofauti wa Faith (
      <italic>
       r
      </italic>
      = −0.297;
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0275) (Mchoro wa ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S9
      </xref>
      ). Thamani za
      <italic>
       p
      </italic>
      zilizowasilishwa hapa zimebadilishwa kwa majaribio mengi.
     </p>
    </sec>
    <sec id="Sec9">
     <title>
      Sifa za microbiota na utambuzi
     </title>
     <p id="Par23">
      Kwa kutumia mbinu ya uchambuzi wa uhusiano kati ya uwezo wa kimwili (muda wa kuinuka kutoka kwenye kiti) na sifa za microbiota hapo juu, tuliona sifa tano za microbiota ambazo zilihusiana kwa kiasi kikubwa na uwezo wa kiakili (alama ya kipengele cha utambuzi) wakati wa kurekebisha kwa athari za mkono na jozi za mapacha na marekebisho ya upendeleo kwa athari za muundo wa wingi wa taxon (Mchoro wa Ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S10
      </xref>
      ). Hii ilijumuisha phylum Actinobacteria (
      <italic>
       r
      </italic>
      = −0.323;
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0447), ambayo iliongezeka kwa kiasi kikubwa katika kundi la prebiotic ikilinganishwa na placebo mwishoni mwa utafiti. Mahusiano kati ya kuboreshwa kwa alama ya kipengele cha utambuzi pia yalihusishwa na ongezeko la wingi wa jamaa wa Veillonellaceae na mpangilio wake wa Veillonelalles kutoka mwanzo wa utafiti hadi mwisho (
      <italic>
       r
      </italic>
      = 0.585,
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0555, na
      <italic>
       r
      </italic>
      = 0.543,
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0772, mtawalia (Mchoro wa Ziada
      <xref ref-type="supplementary-material" rid="MOESM1">
       S9
      </xref>
      ).
     </p>
    </sec>
   </sec>
  </sec>
  <sec id="Sec10" sec-type="discussion">
   <title>
    Majadiliano
   </title>
   <p id="Par24">
    Kuzeeka kunahusishwa na kuongezeka kwa udhaifu na kuzorota kwa utambuzi, zote mbili ambazo zinaweza kuhusisha jukumu la microbiome ya utumbo. Katika RCT hii, tulionyesha kuwa prebiotic ilivumiliwa vizuri kwa ujumla na ilisababisha mabadiliko katika microbiome ya utumbo, hasa kwa ongezeko la wingi wa jamaa wa
    <italic>
     Bifidobacterium
    </italic>
    <sup/>
    . Licha ya hili, hakukuwa na tofauti kubwa katika matokeo ya msingi ya muda wa kuinuka kutoka kwenye kiti kati ya prebiotic na placebo, hata hivyo prebiotic iliboresha utambuzi ikilinganishwa na placebo.
   </p>
   <sec id="Sec11">
    <title>
     Nguvu na kazi ya misuli
    </title>
    <p id="Par25">
     Hakuna ushahidi uliopatikana kwamba prebiotic hii iliboresha nguvu za misuli ikilinganishwa na placebo katika kipindi cha wiki 12, hasa kwa matokeo yetu ya msingi ya muda wa kuinuka kutoka kwenye kiti. Aidha, hakukuwa na athari ya prebiotic kwenye matokeo mengine ya sekondari yanayohusiana na nguvu za misuli na utendaji ikiwa ni pamoja na nguvu ya kushika mkono, SPPB, au shughuli za kimwili (IPAQ).
    </p>
    <p id="Par26">
     Kipindi cha wiki 12 cha uingiliaji kilichaguliwa kulingana na tafiti za awali za uingiliaji wa prebiotic
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
      ,
      <xref ref-type="bibr" rid="CR33">
       33
      </xref>
     </sup>
     . Hata hivyo, hakuna hata moja iliyolenga nguvu za misuli kama matokeo yao ya msingi. Kipindi hiki cha muda kinaweza kuwa hakikutosha kwa mabadiliko ya misuli kutokea, na inawezekana kwamba kipindi kirefu cha uingiliaji kinahitajika ili kuthamini ushawishi wa moduli ya microbiome ya utumbo kwenye afya ya misuli. Wakati mwongozo wa EWGSOP2 unapendekeza muda wa kuinuka kutoka kwenye kiti kama kipimo cha nguvu za misuli, kazi inayofuata inapaswa kuzingatia kuongeza kipimo cha isometric cha nguvu za misuli ambacho kina uwezo wa kugundua mabadiliko madogo kwenye misuli (mfano, quadriceps) pamoja na muda wa kuinuka kutoka kwenye kiti. Ingawa inachukuliwa kuwa muhimu sana kwa watu wazee, muda wa kuinuka kutoka kwenye kiti ni mchanganyiko, unaotegemea nguvu, usawa, maono, nk na ni mbadala badala ya kipimo cha moja kwa moja cha nguvu. Tofauti kubwa imeripotiwa katika vipimo vya nguvu za misuli kwa watu wazee, ingawa vipimo kama vile muda wa kuinuka kutoka kwenye kiti na nguvu ya kushika mkono vinaweza kutekelezwa kwa urahisi katika mazingira ya kliniki, vipimo vya nguvu vya kina na vya moja kwa moja vinapaswa kuzingatiwa katika utafiti wa baadaye unaolenga kuthibitisha ufanisi wa moduli ya microbiome ya utumbo katika kuboresha matokeo ya misuli kwa watu wazee
     <sup>
      <xref ref-type="bibr" rid="CR34">
       34
      </xref>
     </sup>
     .
    </p>
    <p id="Par27">
     Zaidi ya hayo, hesabu yetu ya ukubwa wa sampuli ilitokana na majaribio ya awali ambayo yalitumia muda wa kuinuka kutoka kwenye kiti kama matokeo yao ya msingi
     <sup>
      <xref ref-type="bibr" rid="CR35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="CR36">
       36
      </xref>
      ,
      <xref ref-type="bibr" rid="CR37">
       37
      </xref>
     </sup>
     . Hata hivyo, hakuna jaribio lililokuwepo ambalo lilitumia uingiliaji wa microbiome, na kwa hivyo inawezekana kwamba utafiti ulikuwa na nguvu ndogo. Kwa kweli, ni moja tu ya tano (14/65; 8 katika mkono wa prebiotic, 6 katika mkono wa placebo,
     <italic>
      p
     </italic>
     = 0.68) ya wale ambao walikuwa na muda wa kuinuka kutoka kwenye kiti kupimwa katika mwanzo na mwisho wa utafiti walipata uboreshaji wa 20%, ambao ulikuwa uboreshaji uliokadiriwa kutumika katika hesabu ya ukubwa wa sampuli.
    </p>
    <p id="Par28">
     Kipimo cha prebiotic kilitegemea jaribio lililotumia uingiliaji huo huo kwa wakazi wa nyumba za wazee
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
     </sup>
     . Utafiti uliofanywa na Tandon et al. (2019) ulitafiti kipimo cha fructooligosaccharide (FOS) kwa watu wazima wadogo na kuripoti kutokuwepo kwa tofauti za maana za kistatistiki katika mabadiliko ya microbiota ya utumbo kwa kukabiliana na dozi za 2.5 g/d, 5 g/d na 10 g/d (sachets za PROMOTe zilikuwa na 7.5 g/d), hata hivyo kulikuwa na mwelekeo kuelekea tofauti katika wingi wa
     <italic>
      Lactobacillus
     </italic>
     katika kundi la dozi ya juu zaidi
     <sup>
      <xref ref-type="bibr" rid="CR38">
       38
      </xref>
     </sup>
     . So et al. walifanya uchambuzi wa meta wa uingiliaji wa nyuzi za chakula, nyingi zikiwa ni pamoja na inulin na/au FOS, na waliona hakuna tofauti katika athari kwenye wingi wa
     <italic>
      Bifidobacterium
     </italic>
     na dozi zinazotofautiana
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
     </sup>
     . Walidhani kwamba kunaweza kuwa na kikomo cha kiasi cha nyuzi ambazo Bifidobacterium inaweza kuchachua, au labda ukosefu wa athari ya majibu ya dozi unaweza kuhusishwa na ongezeko la asilimia kutoka msingi badala ya dozi ya uingiliaji
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
     </sup>
     . Matokeo yaliyowasilishwa hapa yanapendekeza dozi ya 7.5 g/d ilikuwa ya kutosha kusababisha mabadiliko ndani ya microbiome ya utumbo. Hata hivyo, hakuna fasihi iliyopo juu ya kipimo cha kutosha cha prebiotics kwa matokeo ya kimwili kama vile nguvu ya misuli. Inawezekana kwamba dozi, ingawa ilikuwa ya kutosha kusababisha mabadiliko ndani ya microbiome ya utumbo, haikuwa ya kutosha kutoa majibu muhimu ya kliniki kwa nguvu ya misuli ndani ya kundi la wajitolea wenye afya.
    </p>
    <p id="Par29">
     Mwishowe, ingawa prebiotic iliyotumika katika jaribio hili ilionyeshwa kuboresha nguvu ya kushika, viwango vya uchovu, na faharisi ya udhaifu katika jaribio lingine la washiriki wazee, inawezekana prebiotic ya inulin/FOS sio prebiotic bora kwa kuathiri afya ya misuli, na utafiti zaidi unahitajika ili kuanzisha prebiotic bora kwa lengo hili
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
      ,
      <xref ref-type="bibr" rid="CR26">
       26
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec12">
    <title>
     Utambuzi
    </title>
    <p id="Par30">
     Kuhusu matokeo ya sekondari, prebiotic iliboresha utambuzi ikilinganishwa na placebo. Kwa kutumia alama ya sababu kuunganisha vipengele vya betri ya utambuzi ya CANTAB, ni vigumu kuripoti kama uboreshaji huu una maana ya kliniki. Jaribio la kipekee la utambuzi ambalo lilikuwa na uboreshaji mkubwa katika vikundi vya prebiotic dhidi ya placebo lilikuwa idadi ya makosa katika jaribio la Kujifunza kwa Wenza, ambalo ni jaribio la kumbukumbu linalolenga hasa kumbukumbu ya kuona na kujifunza mpya
     <sup>
      <xref ref-type="bibr" rid="CR40">
       40
      </xref>
     </sup>
     . Kipimo hiki pia kimebainishwa kama kiashiria cha mapema cha matukio ya magonjwa kama vile Ugonjwa wa Alzheimer
     <sup>
      <xref ref-type="bibr" rid="CR31">
       31
      </xref>
      ,
      <xref ref-type="bibr" rid="CR32">
       32
      </xref>
     </sup>
     .
    </p>
    <p id="Par31">
     Dhana ya mhimili wa utumbo-ubongo, ambapo microbiota inaathiri njia za pande mbili za utumbo-ubongo, imeanzishwa katika miaka ya hivi karibuni
     <sup>
      <xref ref-type="bibr" rid="CR41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="CR42">
       42
      </xref>
     </sup>
     . Kuna fikra kwamba kuna njia kuu tatu za mawasiliano haya ya pande mbili: neva, kinga, na endokrini
     <sup>
      <xref ref-type="bibr" rid="CR41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="CR43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="CR44">
       44
      </xref>
     </sup>
     . Kwa kweli, kuna mwili unaokua wa ushahidi unaounga mkono uingiliaji unaolenga microbiome ya utumbo (ikiwa ni pamoja na prebiotic) katika kuboresha utambuzi
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
     </sup>
     . Desmedt et al. walipitia tafiti za uingiliaji wa prebiotics kwenye athari na utambuzi wa binadamu na walipata tafiti 14 zenye tofauti kubwa katika mbinu, matokeo, dozi ya prebiotic, na muda wa uingiliaji
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
     </sup>
     . Tafiti nyingi zililenga hali ya hisia na athari lakini kulikuwa na maboresho yaliyoonekana katika kumbukumbu ya maneno ya episodic na utambuzi ulioripotiwa. Hakuna tafiti zilizotumia vipimo vya utambuzi vya CANTAB. Hivyo, ili kuthibitisha matokeo yetu, utafiti mkubwa zaidi ambao unajumuisha aina mbalimbali za vipimo vya utambuzi, pamoja na vipimo vya athari na umakini, na vipimo vya kina vya microbiome (muundo na utendaji) unahitajika.
    </p>
   </sec>
   <sec id="Sec13">
    <title>
     Microbiome ya utumbo
    </title>
    <p id="Par32">
     Muhimu, uingiliaji wa prebiotic uliathiri muundo wa microbiota ya utumbo na utendaji wa microbiota ya utumbo. Vipengele arobaini vya microbiome vilibadilika kati ya msingi na mwisho wa utafiti kwa kundi la prebiotic, wakati moja tu ilibadilika katika placebo (Supplementary Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S6
     </xref>
     ). Vipengele hivi ni pamoja na utofauti wa alpha na wingi wa jamaa wa taxa za bakteria. Kupungua kwa utofauti wa alpha kulionekana katika mkono wa prebiotic, ambayo inalingana na matokeo ya vikundi vingine vya utafiti
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
      ,
      <xref ref-type="bibr" rid="CR45">
       45
      </xref>
      ,
      <xref ref-type="bibr" rid="CR46">
       46
      </xref>
     </sup>
     . Prebiotics huwa na kusababisha ongezeko la wingi wa taxa fulani badala ya utofauti mkubwa, kama inavyoonekana katika Fig.
     <xref ref-type="fig" rid="Fig2">
      2
     </xref>
     na Supplementary Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S6
     </xref>
     , ambayo kwa mantiki inaweza kusababisha kupungua kwa utofauti. Kundi la prebiotic lilikuwa na ongezeko kubwa la wingi wa jamaa wa Actinobacteria, hasa
     <italic>
      Bifidobacterium,
     </italic>
     ikilinganishwa na placebo, ambayo imepatikana mahali pengine na utawala wa FOS na/au prebiotic ya inulin
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
      ,
      <xref ref-type="bibr" rid="CR46">
       46
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="CR48">
       48
      </xref>
      ,
      <xref ref-type="bibr" rid="CR49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="CR50">
       50
      </xref>
     </sup>
     . Kwa kushangaza, hakuna ongezeko la
     <italic>
      Lactobacillus
     </italic>
     au
     <italic>
      Facealibacterium
     </italic>
     lililoonekana, zote ambazo zimeripotiwa na wengine wengi katika tafiti za uongezaji wa prebiotic, hasa, fructans za aina ya inulin, wakati wingi wa jamaa wa maagizo ya jenasi mbili, Lactobacillales na Eubacteriales, kwa mtiririko huo, uliongezeka katika kundi la prebiotic ikilinganishwa na placebo, ikionyesha kwamba jenasi zinazohusiana kwa karibu zinaweza pia kuwa na jukumu
     <sup>
      <xref ref-type="bibr" rid="CR38">
       38
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="CR48">
       48
      </xref>
      ,
      <xref ref-type="bibr" rid="CR49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="CR51">
       51
      </xref>
     </sup>
     .
    </p>
    <p id="Par33">
     Inashangaza, licha ya kwamba pacha mmoja kutoka kila jozi alipokea prebiotic na mwingine placebo, hakukuwa na mabadiliko makubwa katika utofauti wa ndani ya pacha mwishoni mwa utafiti. Kazi za awali zimeonyesha kuwa microbiome ya utumbo inaundwa na vinasaba na mazingira ya awali, na upandaji wa mapema na mfululizo wa ikolojia ya jamii. Hivyo, uingiliaji wa prebiotic wa wiki 12 ulikuwa haukutosha kubadilisha usawa kati ya jozi za pacha, ambao wanashiriki vinasaba, athari za mazingira ya awali, na mara nyingi mambo mengine mengi. Uchambuzi wa urithi ulionyesha kuwa baadhi ya taxa ambazo tuligundua zimebadilika katika kipindi cha uingiliaji (mfano
     <italic>
      Bifidobacterium
     </italic>
     ) zilikuwa za kurithi, ambayo inaonyesha kuwa muundo wa utafiti wetu uliimarishwa kwa kutumia jozi za pacha, na muundo huo una uwezekano wa kuongeza uwezo wetu wa kugundua athari
     <sup>
      <xref ref-type="bibr" rid="CR52">
       52
      </xref>
      ,
      <xref ref-type="bibr" rid="CR53">
       53
      </xref>
      ,
      <xref ref-type="bibr" rid="CR54">
       54
      </xref>
      ,
      <xref ref-type="bibr" rid="CR55">
       55
      </xref>
     </sup>
     .
    </p>
    <p id="Par34">
     Kutoka kwa muundo hadi
     <italic>
      kazi
     </italic>
     ya microbiota ya utumbo, GMM kadhaa zilipatikana kuwa na uhusiano mkubwa na uwezo wa kimwili bila kujali mkono wa utafiti na upachikaji wa pacha (Supplementary Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S8
     </xref>
     ). Miongoni mwa hizi zilikuwa njia za kimetaboliki za amino asidi na wanga, pamoja na njia ya pentose phosphate; njia hii hutoa viambajengo vya usanisi wa amino asidi na viungo vya anabolism na ni muhimu katika anabolism ya misuli ya mifupa
     <sup>
      <xref ref-type="bibr" rid="CR56">
       56
      </xref>
      <xref ref-type="bibr" rid="CR57">
       57
      </xref>
      ,
      <xref ref-type="bibr" rid="CR58">
       58
      </xref>
     </sup>
     . Ugunduzi huu unaongeza uzito kwa nadharia ya mhimili wa utumbo-misuli, ambayo inasema kuwa kuna uhusiano wa pande mbili kati ya microbiota ya utumbo na misuli ya mifupa, ambayo inaweza kuwa na athari za kimekanika katika atrophy ya misuli inayohusiana na umri, na inahitaji uchunguzi zaidi katika tafiti zijazo zinazolenga jukumu la microbiome ya utumbo katika upinzani wa anabolic unaohusiana na umri wa misuli ya mifupa
     <sup>
      <xref ref-type="bibr" rid="CR18">
       18
      </xref>
     </sup>
     .
    </p>
    <p id="Par35">
     Kuna ushahidi unaoongezeka unaounga mkono mhimili wa utumbo-ubongo, mfumo wa mawasiliano wa pande mbili kati ya mifumo ya neva ya kati na ya utumbo, ambapo microbiota ya utumbo ina jukumu muhimu la ushawishi
     <sup>
      <xref ref-type="bibr" rid="CR59">
       59
      </xref>
     </sup>
     . Hapa, tunaripoti uhusiano mzuri kati ya ongezeko la alama ya kipengele cha utambuzi na wingi wa jamaa wa Actinobacteria mwishoni mwa utafiti, hata baada ya kurekebisha kwa wingi wa msingi, mkono wa utafiti, na upachikaji wa pacha (Supplementary Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S10
     </xref>
     ). Actinobacteria imehusishwa na utambuzi mahali pengine na imehusishwa na ugonjwa wa Alzheimer na ugonjwa wa Parkinson
     <sup>
      <xref ref-type="bibr" rid="CR60">
       60
      </xref>
      ,
      <xref ref-type="bibr" rid="CR61">
       61
      </xref>
      <xref ref-type="bibr" rid="CR62">
       62
      </xref>
     </sup>
     . Mwelekeo wa uhusiano hutofautiana kati ya tafiti. Wakati imehusishwa na hali za ugonjwa, utafiti mmoja wa watu wazima 39 uliripoti wingi wa juu kuhusishwa na kasi bora ya motor na umakini
     <sup>
      <xref ref-type="bibr" rid="CR63">
       63
      </xref>
     </sup>
     . Actinobacteria ni phylum ambayo jenasi
     <italic>
      Bifidobacterium
     </italic>
     inahusiana nayo; hivyo, ni muhimu kwamba tafiti kadhaa za uingiliaji wa probiotic unaotegemea
     <italic>
      Bifidobacterium
     </italic>
     zimeonyesha maboresho ya kuahidi katika utambuzi
     <sup>
      <xref ref-type="bibr" rid="CR64">
       64
      </xref>
     </sup>
     . Utafiti zaidi unahitajika kuelewa uhusiano kati ya Actinobacteria na kazi ya utambuzi.
    </p>
   </sec>
   <sec id="Sec14">
    <title>
     Uwezekano wa utafiti
    </title>
    <p id="Par36">
     Asili ya mbali ya jaribio hili la kliniki ni nguvu wazi na inathibitisha kuwa uingiliaji unaotolewa kwa mbali unaweza kusimamiwa kwa mafanikio kwa watu wazima, na data kubwa iliyokusanywa na ufuasi mzuri. Muundo huu wa utafiti unaahidi kuboresha uwakilishi mdogo wa watu wazima katika utafiti. Miili ya kitaifa imeita kwa ujumuishaji mkubwa katika utafiti wa kliniki, ikitambua watu wazima kama kundi lisilotumikiwa, na kutambua safari kama kikwazo kikuu katika ushiriki wao
     <sup>
      <xref ref-type="bibr" rid="CR65">
       65
      </xref>
      ,
      <xref ref-type="bibr" rid="CR66">
       66
      </xref>
     </sup>
     . Aidha, vigezo vya kutengwa kwa ajili ya uandikishaji vilibuniwa kuwa vya kujumuisha kadri inavyowezekana kwa watu wazima, ikiwa ni pamoja na wale wanaoishi na udhaifu na magonjwa mengi.
    </p>
    <p id="Par37">
     Matukio mabaya zaidi yalibainika katika kundi la prebiotic; hata hivyo, haya yalikuwa madhara yanayotarajiwa kwa kiasi kikubwa, ambayo washiriki walikuwa wamearifiwa kabla. Hakukuwa na tofauti katika ufuasi kati ya mikono miwili, ikionyesha kuwa madhara haya hayakuathiri utiifu. Hivyo, utafiti huu umeonyesha uwezekano wa kusimamia uingiliaji wa microbiome ya utumbo ambao ni wa bei nafuu na unapatikana kibiashara kwa idadi ya watu wazima. Tafiti za siku zijazo za kiwango kikubwa zaidi zinazotumia ukubwa mkubwa wa sampuli, vipindi virefu vya uingiliaji, na labda maelezo tofauti ya dozi zinaweza kuchunguza uwezo wa microbiome ya utumbo kupatanisha upinzani wa anabolic wa misuli ya mifupa kwa protini kwa watu wazima.
    </p>
   </sec>
   <sec id="Sec15">
    <title>
     Nguzo na mapungufu
    </title>
    <p id="Par38">
     Nguvu kuu ya jaribio hili ni matumizi ya jozi za pacha zilizoratibiwa kwa kila mkono wa utafiti, ambayo ilisababisha mikono inayolingana sana mwanzoni, kuboresha uwezo wa kugundua athari za maana na kupunguza kuchanganya. Aidha, muundo huo ulikuwa jaribio la kivitendo ndani ya kikundi, ambalo lilisababisha uandikishaji wa mafanikio wa ukubwa wa sampuli kwa wakati na lengo.
    </p>
    <p id="Par39">
     Ubunifu wa utafiti wa mbali ni nguvu, kwani kuna haja wazi ya miundo ya majaribio bunifu katika mazingira ya utafiti baada ya COVID, na kupunguza hitaji la kusafiri kwa washiriki wazee, ambao huenda hawataki kuja katika mazingira ya hospitali au ambao wanaweza kuwa na matatizo ya uhamaji. Majaribio ya mbali yanaweza pia kusababisha kupunguzwa kwa gharama za utafiti. Hata hivyo, utoaji wa mbali unaweza kuwaacha wale ambao hawana ujuzi wa kidijitali au ambao hawana kompyuta/kibao na/au mtandao. Hii inaweza kuathiri kwa kiasi kikubwa wale wenye elimu ya chini, viwango vya juu vya umaskini, Kiingereza kama lugha ya pili, na mambo mengine yanayohusiana
     <sup>
      <xref ref-type="bibr" rid="CR66">
       66
      </xref>
     </sup>
     . Ukusanyaji wa data unaweza pia kuwa usio sahihi zaidi kuliko unavyofanywa ana kwa ana, ingawa matumizi ya mawasiliano ya video yalipunguza tatizo hili.
    </p>
    <p id="Par40">
     Ubunifu wa mbali ulisababisha kutoweza kupima uzito wa misuli, ambayo ni kikwazo. Ingawa uzito wa misuli ni moja ya vipengele vya utambuzi wa sarcopenia, mwongozo wa Kikundi cha Kazi cha Ulaya cha Sarcopenia ya Watu Wazee 2 (EWGSOP2) unapendekeza nguvu za misuli kama kipengele muhimu zaidi cha utambuzi
     <sup>
      <xref ref-type="bibr" rid="CR67">
       67
      </xref>
     </sup>
     . Tafiti za baadaye zinazochunguza uingiliaji unaolenga mhimili wa utumbo-misuli zinapaswa kujumuisha kipimo cha uzito wa misuli ili kuchunguza uhusiano huu.
    </p>
    <p id="Par41">
     Upungufu wa data ulikuwa juu zaidi kwa majaribio ya utambuzi ya CANTAB ikilinganishwa na vigezo vingine vya matokeo. Hii huenda ilitokana na mzigo wa kufanya CANTAB nyumbani, ambayo inaweza kuchukua muda mwingi, na programu haipatani na vifaa vyote vya kibao. Baadhi ya washiriki waliokuwa wakitumia vidonge hawakuweza kufanya programu ifanye kazi kwenye vifaa vyao.
    </p>
    <p id="Par42">
     Vipimo vya microbiome ya utumbo vilichukuliwa katika vipindi viwili, mwanzo na mwisho wa utafiti. Bila sampuli ya katikati ya utafiti, hatuwezi kutoa maoni ikiwa matokeo ya microbiota katika mwisho wa utafiti yanaonyesha urejeshaji wa sehemu kutoka kwa uingiliaji wa prebiotic. Ukubwa mkubwa wa sampuli na muda mrefu wa uingiliaji huenda unahitajika ili kujaribu hili. Zaidi ya hayo, uchambuzi wa utendaji wa microbiome ya utumbo katika utafiti huu unategemea data ya metagenomic badala ya kipimo cha moja kwa moja. Utafiti wa baadaye unaweza kuchunguza meta transcriptomics au metabolomics ya kinyesi ili kuchunguza hili zaidi. Maltodextrin ni placebo inayotumika sana katika majaribio ya prebiotics lakini ina mapungufu, kwani haifanani moja kwa moja na prebiotic kwa nishati. Majaribio ya baadaye yanaweza kutumia placebo inayolingana na nishati ili kushinda hili.
    </p>
    <p id="Par43">
     Kikundi cha TwinsUK, ambacho washiriki walichukuliwa, kina wanawake wengi kwa sababu za kihistoria na kina upendeleo wa kujitolea kwa afya
     <sup>
      <xref ref-type="bibr" rid="CR68">
       68
      </xref>
     </sup>
     . Hata hivyo, inawakilisha kwa kiasi kikubwa idadi ya watu wa Uingereza
     <sup>
      <xref ref-type="bibr" rid="CR68">
       68
      </xref>
     </sup>
     . Utafiti huu ulilenga kuangalia wale walio na umri wa zaidi ya miaka 60, na kwa hivyo, hauwezi kuwakilisha makundi ya umri mdogo. Aidha, asili ya washiriki wengi kuwa wanawake inazuia kwa kiasi fulani uwezo wa kuwakilisha. Kazi ya baadaye katika eneo hili inapaswa kujumuisha watu wazima wa umri wa kati, wazee zaidi, na uwakilishi mkubwa wa wanaume.
    </p>
   </sec>
   <sec id="Sec16">
    <title>
     Muhtasari wa majadiliano
    </title>
    <p id="Par44">
     Prebiotics ziliboreshwa utambuzi lakini hazikuathiri nguvu za misuli na kazi, ikilinganishwa na placebo katika kundi la mapacha wazee wenye afya. Matokeo yetu yanaonyesha kuwa uingiliaji wa microbiome ya utumbo ambao ni wa bei nafuu na unapatikana kwa urahisi unaahidi kuboresha udhaifu wa utambuzi katika idadi yetu ya watu wanaozeeka. Ingawa jaribio hili halikuonyesha kuboreshwa kwa nguvu za misuli ya mifupa, tulionyesha kuwa moduli ya microbiome ya utumbo kupitia nyongeza ya prebiotic katika muktadha wa utafiti wa misuli ya kuzeeka inawezekana na inavumiliwa vizuri, na majibu wazi yameonekana katika muundo na kazi ya microbiota ya utumbo. Majaribio makubwa ya baadaye yanaweza kuchunguza matumizi ya uingiliaji unaolenga microbiome ya utumbo kushinda upinzani wa anabolic unaohusishwa na umri. Pia tunaonyesha uwezekano wa majaribio yanayotolewa kwa mbali kwa watu wazee, ambayo yanaahidi kwa tafiti za baadaye katika eneo hili, kwa lengo la kupunguza uwakilishi mdogo wa watu wazee katika majaribio ya kliniki na kupunguza gharama za utafiti.
    </p>
   </sec>
  </sec>
  <sec id="Sec17" sec-type="methods">
   <title>
    Mbinu
   </title>
   <p id="Par45">
    Muundo wa utafiti umeelezewa kwa kina katika itifaki iliyochapishwa awali
    <sup>
     <xref ref-type="bibr" rid="CR69">
      69
     </xref>
    </sup>
    . Kwa kifupi, jaribio la PROMOTe (athari za PRebiotic na prOtein kwenye Misuli kwa Mapacha Wazee) lilikuwa jaribio la kudhibitiwa la nasibu ambapo jozi za mapacha (monozygotic na dizygotic) zilirandomishwa, pacha mmoja kwa kila mkono wa utafiti. Mapacha wote walitumia unga wa nyongeza ya protini (BCAA), na kwa pacha mmoja kutoka kila jozi, hii ilijumuishwa na nyongeza ya prebiotic (inulin na fructo-oligosaccharides) na kwa pacha mwingine kutoka kila jozi, ilijumuishwa na placebo (maltodextrin). Nyongeza hizi zilizochanganywa awali zilikuwa katika mifuko inayofanana, na kila mshiriki alishauriwa kuchukua mfuko mmoja kwa siku kwa wiki 12 katika glasi ya maji au kinywaji kingine kwa wakati mmoja kila siku. Tuliwashauri washiriki katika makundi yote mawili kufanya mazoezi ya upinzani.
   </p>
   <p id="Par46">
    Jaribio hili lilitolewa kwa mbali, kwa kutumia vifurushi vya posta kusambaza uingiliaji na kukusanya vipimo na sampuli kutoka kwa washiriki na aina mbalimbali za teknolojia, ikiwa ni pamoja na mawasiliano ya video, dodoso za mtandaoni, upimaji wa utambuzi mtandaoni, na programu ya shajara ya chakula mtandaoni. Muundo huu wa utafiti wa mbali uliochaguliwa kwa sehemu kutokana na janga la COVID-19 na vizuizi vya usafiri vilivyohusishwa, pamoja na wasiwasi wa washiriki wazee kuhusu kuhudhuria hospitali. Zaidi ya hayo, watu wengi wazee wanaweza kupata ugumu wa kusafiri kwa sababu mbalimbali na Taasisi ya Kitaifa ya Utafiti wa Afya imeita miundo ya utafiti bunifu ili kuboresha ujumuishaji wa makundi yasiyowakilishwa vizuri, ikiwa ni pamoja na watu wazima
    <sup>
     <xref ref-type="bibr" rid="CR66">
      66
     </xref>
     ,
     <xref ref-type="bibr" rid="CR70">
      70
     </xref>
    </sup>
    . Hii ilirahisishwa na ongezeko la ujuzi wa kiteknolojia na mtandao miongoni mwa watu wazee, ambao uliongezeka kwa kasi kutokana na vizuizi vya janga la COVID-19
    <sup>
     <xref ref-type="bibr" rid="CR71">
      71
     </xref>
     ,
     <xref ref-type="bibr" rid="CR72">
      72
     </xref>
    </sup>
    .
   </p>
   <p id="Par47">
    Mtiririko wa utafiti na vipimo vilivyofanywa vinaonyeshwa katika Fig.
    <xref ref-type="fig" rid="Fig3">
     3
    </xref>
    <sup/>
    . Washiriki wote walitumwa kifurushi cha posta kilicho na vifaa vyote muhimu na maelekezo ya kuchukua sampuli za kibayolojia, ikiwa ni pamoja na bahasha za kurudisha zilizolipiwa, dynamometer ya kupima nguvu ya mkono (Kuptone; Model EH101), utepe wa mita nne kusaidia kupima kasi ya kutembea na kipimo cha urefu. Washiriki walikuwa na fursa ya kuwauliza watafiti mwongozo zaidi juu ya kipengele chochote cha jaribio wakati wa ziara ya mawasiliano ya video.
    <fig id="Fig3" position="float">
     <label>
      Fig. 3
     </label>
     <caption xml:lang="en">
      <title>
       Chati ya mtiririko wa utafiti.
      </title>
      <p>
       Maelezo: Chati hii ya mtiririko ilichapishwa awali katika itifaki ya utafiti
       <sup>
        <xref ref-type="bibr" rid="CR70">
         70
        </xref>
       </sup>
       . Imenakiliwa kwa ruhusa kutoka kwa Ni Lochlainn et al.
       <sup>
        <xref ref-type="bibr" rid="CR70">
         70
        </xref>
       </sup>
       .
      </p>
     </caption>
     <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-46116-y/41467_2024_46116_Fig3_HTML.png" mime-subtype="PNG" specific-use="web"/>
    </fig>
   </p>
   <p id="Par48">
    Takwimu za jinsia zilitegemea ripoti za kibinafsi kutoka kwa washiriki. Mapacha wote walikuwa wa jinsia moja. Jinsia haikukusanywa. Vipimo vya urefu vilifanywa na mshiriki kwa kutumia kipimo kilichotolewa katika kifurushi cha posta. Washiriki waliombwa kujipima uzito ikiwa walikuwa na mizani ya kupima uzito. Mizani ya kupima uzito inaweza kukaguliwa kwa kutumia kipengee cha kawaida cha nyumbani, kama vile kopo la maharagwe. Betri ya Utendaji wa Kimwili Mfupi (SPPB) ilifanywa kwa mbali (hii inajumuisha muda wa kuinuka kwenye kiti), kwa maelekezo ya wakati halisi kutoka kwa mtafiti aliyefunzwa. Nguvu ya mkono ilipimwa kwa kutumia dynamometer iliyotolewa, kwa mwongozo kutoka kwa mtafiti aliyefunzwa, wakati wa simu ya video. Sampuli za kinyesi zilichukuliwa na washiriki wenyewe kwa kutumia vifaa vya kukusanya sampuli vilivyotolewa. Mapacha waliombwa kukusanya sampuli ya kinyesi "kama ukubwa wa mbaazi" kwenye Tube ya Kukusanya Kinyesi ya DNA/RNA Shield (Zymo Research), na hizi zilitumwa kwa maabara. Baada ya kupokelewa, sampuli zilichakatwa kwa kutumia shanga za glasi, vortexing, centrifugation na kugawa supernatant kwa uhifadhi wa muda mfupi na wa muda mrefu katika −80 °C. Uchimbaji wa DNA ya vijidudu ulifanywa kwenye sampuli zote kwa kutumia Kit maalum cha MagMax Core Nucleic Acid Purification na Moduli ya MagMax Core Mechanical Lysis. Itifaki iliboreshwa kwa uzito wa kuanzia wa kinyesi wa 1 g/ml na ujazo wa mwisho wa elution wa 100 µl. DNA iliyofuata ilihifadhiwa katika −20 °C kwa muda mrefu. DNA ya vijidudu ilitumwa kwa
    <italic>
     Clinical Microbiomics Ltd
    </italic>
    <sup/>
    . kwa ajili ya tabia ya microbiota ya utumbo kwa kutumia upimaji wa metagenomic wa shotgun (angalia Maelezo ya Ziada
    <xref ref-type="supplementary-material" rid="MOESM1">
     1
    </xref>
    kwa mbinu za kina).
   </p>
   <p id="Par49">
    Vipimo vya utambuzi kutoka kwenye betri ya CANTAB vilijumuisha vipimo vya utendaji wa kiutawala, yaani One Touch Stockings of Cambridge na vipimo vya kumbukumbu ya anga, na vipimo vya kumbukumbu, yaani span ya anga, utambuzi wa muundo wa kumbukumbu, na kujifunza kwa washirika waliopangwa
    <sup>
     <xref ref-type="bibr" rid="CR40">
      40
     </xref>
    </sup>
    . Data za shajara ya chakula ya siku tatu ziliingizwa na kuchambuliwa kwenye programu ya mtandaoni ya
    <italic>
     MyFood24
    </italic>
    <sup>
     <xref ref-type="bibr" rid="CR73">
      73
     </xref>
     ,
     <xref ref-type="bibr" rid="CR74">
      74
     </xref>
    </sup>
    .
   </p>
   <p id="Par50">
    Washiriki walizingatiwa kufuata nyongeza ikiwa walijibu swali 'Je, umekuwa ukichukua nyongeza zako kila siku?' kwa 'Ndiyo—kila siku' au 'Karibu kila siku' na walizingatiwa kufuata mazoezi ikiwa waliripoti kufanya mazoezi mara mbili kwa wiki au zaidi. Mwishowe, washiriki waliulizwa kuweka sachets zilizobaki katika ziara yao ya mwisho ya video ili ziweze kuhesabiwa. Nambari hii ililinganishwa na idadi ya siku tangu mshiriki aanze utafiti, na asilimia ya ufuasi ilihesabiwa. Utafiti huu ulisajiliwa na ClinicalTrials.gov (NCT04309292).
   </p>
   <sec id="Sec18">
    <title>
     Vigezo vya kuingiza/kutoa
    </title>
    <p id="Par51">
     Washiriki walikuwa na sifa za kujumuishwa ikiwa walikuwa na umri wa miaka 60 au zaidi na walikuwa wameripoti ulaji wa chini wa protini ya chakula (
    </p>
   </sec>
   <sec id="Sec19">
    <title>
     Uingiliaji wa Utafiti
    </title>
    <p id="Par52">
     Washiriki walipewa sachets za virutubisho vya chakula katika mfumo wa unga. Sachets zote zilikuwa na 3.32 g ya unga wa protini ya amino asidi yenye matawi, inayojumuisha
     <sc>
      l
     </sc>
     -leucine 1660 mg,
     <sc>
      l
     </sc>
     -isoleucine 830 mg, na
     <sc>
      l
     </sc>
     -valine 830 mg. Sachets za mkono wa uingiliaji pia zilikuwa na 7.5 g ya prebiotic (Darmocare Pre®, Bonusan), ambayo inajumuisha inulin (min. 3375 mg) na fructo-oligosaccharides (FOS) (min. 3488 mg). Sachets za placebo zilikuwa na 7.5 g ya unga wa maltodextrin. Virutubisho vyote hivi vya chakula vinapatikana kibiashara bila agizo la daktari. Uchaguzi wa prebiotic ulitokana na jaribio lililotumia uingiliaji huo huo, ambalo lilionyesha kuboreshwa kwa nguvu ya mkono na viwango vya uchovu, vigezo viwili vya udhaifu wa Fried katika idadi ya wazee
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
     </sup>
     . Maltodextrin hutumiwa kawaida kama placebo katika tafiti za microbiome ya utumbo na uingiliaji wa lishe
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
     </sup>
     .
    </p>
    <p id="Par53">
     Sachets kwa mikono yote miwili zilitengenezwa kuwa katika sachets zisizotofautishwa, zinazotambulika kwa nambari ya nasibu, ambayo ilikuwa inapatikana tu na Kitengo cha Majaribio ya Kliniki cha King (KCTU), ambacho kilifanya upangaji wa nasibu kwa ajili ya utafiti. Upangaji wa nasibu na ugawaji wa mikono ulifanywa kwa mbali na KCTU, ambao walitoa nambari inayolingana kwa sachets sahihi kutumwa kwa kila mshiriki na timu ya utafiti. Upangaji wa nasibu ulifanywa kama jozi za mapacha, kila jozi kama kizuizi cha kudumu cha wawili—pacha mmoja katika kila jozi aligawanywa kwa nasibu kwa kila mkono. Washiriki wote na watafiti walikuwa wamefichwa hadi uchambuzi wa data ulipokamilika.
    </p>
    <p id="Par54">
     Washiriki wote waliombwa kuhifadhi sachet zozote zilizobaki mwishoni mwa kipindi cha majaribio kama kipimo cha kufuata maagizo. Mwishowe, washiriki wote walihimizwa kushiriki katika mazoezi ya upinzani mara kwa mara angalau mara mbili kwa wiki wakati wote wa uingiliaji na walipewa ushauri wa maandishi kuhusu hili mwanzoni mwa utafiti, inapatikana kutoka kwenye tovuti ya NHS:
     <ext-link ext-link-type="uri" href="https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/">
      https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/
     </ext-link>
     <sup>
      <xref ref-type="bibr" rid="CR75">
       75
      </xref>
     </sup>
     . Mazoezi ya nguvu yalijumuisha squats, kuinua visigino, kusimama kutoka kwenye kiti, kuinua miguu, kunyoosha miguu, kupiga kuta na kuinua mikono. Mazoezi haya yanashauriwa mara kwa mara kwa wazee, yanaweza kufanywa nyumbani kwao, na hayawakilishi mpango mkubwa wa mazoezi. Vikumbusho vya ujumbe wa maandishi vilitumwa kila wiki wakati wote wa kipindi cha uingiliaji ili kuhimiza kufuata maagizo na sachet za virutubisho.
    </p>
   </sec>
   <sec id="Sec20">
    <title>
     Matokeo
    </title>
    <p id="Par55">
     Matokeo yalikusanywa katika ziara za utafiti kupitia mawasiliano ya video, kupitia kukamilisha dodoso kwa mbali, shajara ya chakula ya siku 3 kupima protini na ulaji mwingine wa chakula ili kuzingatia tofauti zozote katika ulaji ambazo zinaweza kusababisha kuchanganya na betri ya mtihani wa utambuzi, na kupitia kupokea sampuli za kibaiolojia kwa njia ya posta kutoka kwa washiriki. Matokeo ya msingi yalikuwa ni mabadiliko katika muda wa kuinuka kutoka kwenye kiti (muda wa kufanya kuinuka mara 5 bila kutumia mikono), kipimo kilichofanywa mwanzoni na mwishoni mwa utafiti. Muda wa kuinuka kutoka kwenye kiti ni sehemu ya betri ya utendaji wa kimwili mfupi na unahusishwa na ubora wa maisha, utendaji wa kimwili, udhaifu, magonjwa mengi na, kwa kweli, utambuzi
     <sup>
      <xref ref-type="bibr" rid="CR76">
       76
      </xref>
      ,
      <xref ref-type="bibr" rid="CR77">
       77
      </xref>
     </sup>
     . Ni kipimo kilichopendekezwa cha nguvu katika mwongozo wa Kikundi cha Kazi cha Ulaya cha Sarcopenia ya Watu Wazee 2
     <sup>
      <xref ref-type="bibr" rid="CR67">
       67
      </xref>
     </sup>
     .
    </p>
    <p id="Par56">
     Matokeo ya sekondari yalijumuisha alama ya kipengele cha betri ya utambuzi, alama ya SPPB (inajumuisha muda wa kuinuka kutoka kwenye kiti na kasi ya kutembea), nguvu ya kushika, kasi ya kutembea, viwango vya shughuli za kimwili vilivyoripotiwa na kutumia Dodoso la Shughuli za Kimwili la Kimataifa (IPAQ) na alama ya hamu ya kula ya Dodoso la Tathmini ya Lishe Rahisi (SNAQ).
    </p>
   </sec>
   <sec id="Sec21">
    <title>
     Microbiome ya utumbo
    </title>
    <p id="Par57">
     Mbinu kamili ya uainishaji wa microbiome ya utumbo inatolewa katika Kumbuka ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      1
     </xref>
     <sup/>
     . Kwa muhtasari, jumla ya sehemu 137 za DNA zilifuatiliwa kwa kina cha wastani cha jozi za kusoma milioni 21.6 (M) (Illumina 2 × 150 PE) kwa sampuli. Uchafuzi wa mwenyeji uliondolewa, adapta na besi ziliondolewa kwa kukata, na jozi za kusoma ambazo zilipita uchujaji zikiwa na urefu wa angalau 100 bp zilihifadhiwa; hizi ziliorodheshwa kama usomaji wa hali ya juu usio wa mwenyeji (HQNH). 82.8% ya usomaji wa HQNH ulipangwa kwenye orodha ya jeni za utumbo wa binadamu ya Clinical Microbiomics kwa kutumia BWA mem (v. 0.7.17)
     <sup>
      <xref ref-type="bibr" rid="CR78">
       78
      </xref>
     </sup>
     . Aina 326 za Metagenomic (MGSs) zilipatikana kwa wastani kwa sampuli. Ili kutaja kijenetiki MGS, jeni zake zilipigwa dhidi ya jenomu za prokaryotic za NCBI RefSeq (2022-01-19), na hifadhidata za nt (2021-08-03) na vigezo maalum vya uainishaji vilitumika. Profaili za wingi wa MGS zilizopunguzwa zilikokotwa kwa sampuli ya nasibu, bila kubadilisha, ya idadi maalum ya hesabu za jeni za saini kwa sampuli na kisha kufuata utaratibu ulioelezwa hapo juu. Katika utafiti huu, hesabu 431127 za jeni za saini zilifuatiliwa. Uainishaji wa kazi na upimaji wa microbiome ulifanywa kwa kutumia EggNOG mapper (v. 2.0.1), hali ya Diamond, na moduli za KEGG (v. 78.2)
     <sup>
      <xref ref-type="bibr" rid="CR79">
       79
      </xref>
      <xref ref-type="bibr" rid="CR80">
       80
      </xref>
     </sup>
     .
    </p>
    <p id="Par58">
     Uchambuzi wote wa microbiome ulitumia wingi wa jamaa kwa kulinganisha makundi, wakati makadirio ya utofauti wa alpha na beta yalihesabiwa kutoka kwa matriki ya wingi wa nadra yaliyoundwa kwa sampuli ya nasibu ya usomaji bila kubadilisha. Utofauti wa Alpha unarejelea utofauti ndani ya sampuli, wakati vipimo vya utofauti wa beta ni makadirio ya kufanana/kutofautiana kati ya sampuli
     <sup>
      <xref ref-type="bibr" rid="CR81">
       81
      </xref>
     </sup>
     . Ndani ya kila aina ya data (mfano, jeni, MGS), sampuli zote ziliwakilishwa na idadi sawa ya usomaji wa mfuatano wa taarifa: upunguzaji wa wingi wa MGS ulifanywa kwa sampuli tu kutoka kwa usomaji unaopangwa kwa jeni za saini za MGS, na upunguzaji wa wingi wa orthology ya Kyoto Encyclopaedia of Genes and Genomes (KEGG) ulifanywa kwa sampuli tu kutoka kwa usomaji uliopangwa kwa jeni iliyo na KO iliyotolewa. Hata hivyo, upunguzaji wa wingi wa jeni ulifanywa kwa sampuli ya usomaji uliopangwa kwa orodha nzima ya jeni. Utofauti wa Alpha ulipimwa kama idadi ya vijiumbe vilivyogunduliwa (utajiri), kama fahirisi ya Shannon inayotegemea logi asilia, au kama utofauti wa kijenetiki wa Faith. Utofauti wa Beta ulipimwa kama tofauti ya Bray–Curtis na umbali wa UniFrac wenye uzito.
    </p>
    <p id="Par59">
     Ulinganifu kati ya mapacha ulifanyiwa uchunguzi kwa kutumia kipimo cha Mann–Whitney
     <italic>
      U
     </italic>
     na kulinganisha na mapacha wasiofanana kwa kuwa kuna sababu nyingi za ndani na za kimazingira, kama vile lishe, jiografia, aina ya makazi, hali ya kuishi pamoja, na vinasaba vya mwenyeji vinavyoathiri microbiome ya mwenyeji
     <sup>
      <xref ref-type="bibr" rid="CR82">
       82
      </xref>
     </sup>
     . Uchambuzi rasmi wa urithi ulifanywa kwa kutumia mfano wa ACE kama ilivyoelezwa, ili kushughulikia kama ulinganifu wa microbiota kati ya mapacha unaweza kuhusishwa na urithi wa taxa za microbial
     <sup>
      <xref ref-type="bibr" rid="CR52">
       52
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec22">
    <title>
     Hesabu ya ukubwa wa sampuli
    </title>
    <p id="Par60">
     Kutoka kwa data iliyopo ndani ya kundi la TwinsUK, tuliona kuwa muda wa kuinuka kutoka kwenye kiti ulikuwa takriban log-normal, na log10(muda wa kuinuka kutoka kwenye kiti) ukiwa na SD ya 0.126. Tuliona kupungua kwa muda wa kuinuka kutoka kwenye kiti kwa 20% kuwa kunawezekana na ni muhimu kiafya. Tulitegemea hili kwa tafiti za awali zinazotumia muda wa kuinuka kutoka kwenye kiti, hata hivyo, ilibainika kuwa hakuna utafiti uliokuwa umechunguza hili katika muktadha wa uingiliaji unaolenga microbiome ya utumbo. Kulingana na takwimu hizi, tulihesabu kuwa tungehitaji data kamili kwa washiriki 28 kwa kila kundi (56 jumla) kwa nguvu ya 80%. Tukiruhusu 20% ya kuacha, tulihitaji
     <italic>
      n
     </italic>
     = washiriki 70 walioajiriwa (35 kwa kila kundi). Kutumia mapacha huongeza nguvu ya utafiti kutokana na kufanana kwa karibu katika mwanzo, na kupunguza utofauti wa vinasaba na/au kimazingira, na hivyo kupunguza kuchanganya
     <sup>
      <xref ref-type="bibr" rid="CR35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="CR36">
       36
      </xref>
      ,
      <xref ref-type="bibr" rid="CR37">
       37
      </xref>
      <xref ref-type="bibr" rid="CR83">
       83
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec23">
    <title>
     Uchambuzi wa takwimu
    </title>
    <p id="Par61">
     Uchambuzi ulifanywa kwa kutumia Stata SE toleo la 15.1, isipokuwa uchambuzi wa microbiome ya utumbo, ambao ulifanywa kwa kutumia R toleo la 4.2.1
     <sup>
      <xref ref-type="bibr" rid="CR84">
       84
      </xref>
      <xref ref-type="bibr" rid="CR85">
       85
      </xref>
     </sup>
     . Kufichua makundi ya randomisation kulifanywa tu baada ya uchambuzi wote wa takwimu kukamilika. Thamani ya
     <italic>
      P
     </italic>
     ya pande mbili ya &lt;0.05 ilizingatiwa kuwa muhimu kwa uchambuzi wote. Washiriki hawakutengwa ikiwa walikosa data za msingi za covariate ili kutosheleza kanuni za mbinu ya nia ya kutibu (ITT). Hivyo, kwa data iliyokosekana katika kategoria hii, mbinu za ujazaji wa wastani zilitumika. Vinginevyo, kwa baadhi ya vigezo, thamani ya hivi karibuni kutoka kwa data ya muda mrefu ya kundi la TwinsUK ilijazwa ikiwa ilionekana kuwa ndani ya kipindi kinachofaa. Maamuzi juu ya mbinu za ujazaji yalifanywa kabla ya kufichua.
    </p>
    <p id="Par62">
     Kuhusu data ya matokeo iliyokosekana, kwa madhumuni ya uchambuzi mkuu, ilidhaniwa kuwa data iliyokosekana ilikosekana kwa nasibu, na athari ya uingiliaji ilikuwa sawa kwa wale walio na na bila uchunguzi. Hakuna ushahidi uliopatikana wa kutokuwa na usawa wa data iliyokosekana ndani ya kila mgawanyo wa matibabu.
    </p>
    <p id="Par63">
     Ili kulinganisha wale waliokataa au ambao hawakustahili kushiriki, na wale waliopata kushiriki, data iliyopo ya muda mrefu ya TwinsUK ilitumika. Vipimo vya t vya pande mbili vilivyopangwa vilitumika kulinganisha kila kundi. Tofauti kati ya makundi mawili kwa suala la jinsia ilirekebishwa kwa umri, na vivyo hivyo, tofauti kati ya makundi mawili kwa suala la umri ilirekebishwa kwa jinsia ili kutathmini kama moja ya vigezo hivi ilikuwa inaendesha utofauti kati ya makundi mawili.
    </p>
    <p id="Par64">
     Ili kuainisha tofauti kati ya mikono ya utafiti mwanzoni, vigezo endelevu vililinganishwa kwa kutumia vipimo viwili vya
     <italic>
      t
     </italic>
     na vigezo vya kategoria kwa vipimo vya chi-mraba vya Pearson. Vipimo vya
     <italic>
      t
     </italic>
     vilivyopangwa pande mbili vilitumika kulinganisha data za lishe kati ya mwanzo wa utafiti na mwisho wa utafiti.
    </p>
    <p id="Par65">
     Ili kuchunguza utambuzi kwa ujumla, alama ya uchambuzi wa sababu ilitumika kuunganisha matokeo ya vipimo vitano vya utambuzi (Maelezo ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      2
     </xref>
     ). Mizigo ya sababu kutoka mwanzo wa utafiti ilitumika kwa matokeo ya vipimo vya utambuzi vya mwanzo na mwisho wa utafiti ili kuhakikisha mizigo sawa. Sababu moja ilitambuliwa kutoka kwenye mchoro wa scree kama inayohesabu tofauti kubwa zaidi. Hivyo, alama ya sababu mwanzoni na mwisho wa utafiti ilitolewa na baadaye kutumika katika mifano ya athari mchanganyiko. Mifano ya athari mchanganyiko ya mstari ilitumika kulinganisha vikundi vya uingiliaji kati (mkono 1 dhidi ya mkono 2; bila kujulikana) juu ya mabadiliko yao katika kila matokeo kwa kutumia kipimo cha matokeo hayo mwishoni mwa utafiti na kujumuisha kipimo cha mwanzo katika mfano. Uwekaji wa mapacha ulizingatiwa kama athari ya nasibu, kitambulisho cha familia na zygosity, na kikundi cha matibabu kama athari ya kudumu. Vipimo vya
     <italic>
      t
     </italic>
     vilivyopangwa pande mbili vilitumika kwa kulinganisha ndani ya kikundi kati ya mwanzo na mwisho wa uingiliaji kati.
    </p>
    <p id="Par66">
     Ili kuangalia ulaji wa virutubishi kwa kuripoti kupita kiasi au chini ya kiwango, viwango vya Goldberg vya ulaji wa nishati ikilinganishwa na uwiano wa kiwango cha kimetaboliki ya msingi vilitumika na kuzidishwa na sababu ya 1.4 ili kuzingatia shughuli za mwili
     <sup>
      <xref ref-type="bibr" rid="CR86">
       86
      </xref>
      ,
      <xref ref-type="bibr" rid="CR87">
       87
      </xref>
      <xref ref-type="bibr" rid="CR88">
       88
      </xref>
     </sup>
     . Kiwango cha shughuli za kikazi 'nyepesi' kilichaguliwa kulingana na alama za IPAQ za washiriki mwanzoni.
    </p>
    <p id="Par67">
     Vipengele vya microbiota ya utumbo (muundo, kazi, vipimo vya utofauti, GMMs, na GBMs) vililinganishwa kati ya mikono ya utafiti ya prebiotic na placebo mwanzoni na mwisho wa utafiti kwa kutumia mtihani wa Wilcoxon wa alama zilizotiwa saini. Aidha, kulinganisha ndani ya kikundi kati ya mwanzo na mwisho wa utafiti kulifanywa kwa kila mkono kando. Tulijaribu kama vipengele vyovyote vya microbiota vilihusishwa na matokeo ya msingi ya muda wa kuinuka kwenye kiti ama mwanzoni, mwisho wa utafiti au mabadiliko kati ya hizo mbili. Mabadiliko katika kipengele cha microbiome yaliingizwa katika uchambuzi wa uhusiano dhidi ya mabadiliko katika muda wa kuinuka kwenye kiti na mabadiliko katika alama ya sababu ya utambuzi. Vigezo vyote vya mabadiliko ni tofauti kati ya mwanzo wa utafiti na mwisho wa utafiti. Ili kuhesabu mabadiliko katika vipengele vya microbiota, wingi wa jamaa mbichi ulitumika, na maadili ya delta yaliyotokana yalibadilishwa kuwa uwiano wa logi iliyozingatiwa na kutumika kama ingizo kwa mifano ya mstari.
    </p>
    <p id="Par68">
     Kulinganisha kwa jozi kwa (kutofautiana) kwa microbiota kulifanywa kwa kutumia mtihani wa Mann-Whitney U. Vipimo vya uchambuzi wa tofauti za mabadiliko ya kielelezo (PERMANOVA) vilifanywa kwa kutumia kazi ya adonis2 kutoka kwenye kifurushi cha R cha vegan na mabadiliko 1000. Uchambuzi ulirekebishwa kwa vipimo vingi kwa kutumia mbinu ya Benjamini–Hochberg kudhibiti kiwango cha ugunduzi wa uwongo kwa kiwango cha 10%. Urithi wa maana pana ulitambuliwa kwa kutumia mfano wa ACE (kutoka kwenye kifurushi cha R cha mets). Mfano unakadiria ni kiasi gani cha tofauti ya kimaumbile kinatokana na athari za kijenetiki za kuongeza (A), mazingira ya kawaida (C) na mazingira ya kipekee kwa kila pacha (E). Mfano ulifanywa kando kwa wingi wa taxa zilizopatikana katika zaidi ya sampuli 2 katika kila mkono (
     <italic>
      wingi
     </italic>
     ∼ 1) na kutumika kutoa urithi wa maana pana. Maelezo zaidi juu ya uchambuzi wa takwimu za microbiome ya utumbo yanapatikana katika Maelezo ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      1
     </xref>
     <sup>
      <xref ref-type="bibr" rid="CR89">
       89
      </xref>
      <xref ref-type="bibr" rid="CR90">
       90
      </xref>
      ,
      <xref ref-type="bibr" rid="CR91">
       91
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec24">
    <title>
     Muhtasari wa kuripoti
    </title>
    <p id="Par69">
     Maelezo zaidi juu ya muundo wa utafiti yanapatikana katika
     <xref ref-type="supplementary-material" rid="MOESM3">
      Muhtasari wa Ripoti ya Nature Portfolio
     </xref>
     iliyounganishwa na makala hii.
    </p>
   </sec>
  </sec>
 </body>
 <back>
  <ack>
   <title>
    Shukrani
   </title>
   <p>
    Waandishi wangependa kutambua Taasisi ya Kitaifa ya Utafiti wa Afya kwa kufadhili utafiti huu. Pia tungependa kutambua wafanyakazi wa utafiti katika Idara ya Utafiti wa Mapacha na washiriki wote. Tunapenda hasa kumshukuru Deborah Hart, Ayrun Nessa, Alyce Sheedy, na Gulsah Akdag ambao walichangia sana katika uendeshaji wa jaribio la PROMOTe. Tunawashukuru Jopo la Ushauri la Wajitolea la TwinsUK kwa maoni yao ya busara na maoni kuhusu muundo wa utafiti. Pia tungependa kumshukuru Roosa Varjus kwa kuchangia katika uchambuzi wa microbiome. Utafiti huu ulifadhiliwa kwa pamoja na Kings College London na Guy’s na St Thomas’ NHS Trust. Hakuna mdhamini aliyekuwa na jukumu katika muundo wa utafiti, ukusanyaji wa data na uchambuzi au uandishi wa maandiko. MNL inasaidiwa na Ushirika wa Udaktari wa NIHR (msimbo wa ruzuku: NIHR300159). C.J.S. anapokea fedha kutoka Baraza la Utafiti wa Matibabu (MRC), Wellcome Trust (msimbo wa ruzuku WT 212904/Z/18/Z), na Msingi wa Utafiti wa Magonjwa Sugu. K.W. amepokea fedha kutoka MRC, NIHR, Crohn’s na Colitis UK, Msingi wa Kenneth Rainin, Leona M. na Harry B. Helmsley Charitable Trust, Bodi ya Almond ya California, Danone, na Baraza la Kimataifa la Matunda Makavu. TwinsUK inafadhiliwa na Wellcome Trust, Wellcome LEAP, Baraza la Utafiti wa Matibabu, Versus Arthritis, Baraza la Utafiti wa Sayansi ya Uhandisi na Fizikia, Baraza la Utafiti wa Bioteknolojia na Sayansi ya Biolojia, Tume ya Ulaya, Msingi wa Utafiti wa Magonjwa Sugu (CDRF), Zoe Ltd., Taasisi ya Kitaifa ya Utafiti wa Afya na Huduma (NIHR) Mtandao wa Utafiti wa Kliniki (CRN) na Kituo cha Utafiti wa Biomedical kilichoko Guy’s na St Thomas’ NHS Foundation Trust kwa ushirikiano na King’s College London. Programu ya kuripoti lishe ya myfood24 ilitumika katika utafiti huu. myfood24 ilitengenezwa kupitia ufadhili wa Baraza la Utafiti wa Matibabu, ruzuku G110235. myfood24 sasa inasaidiwa na kampuni ya spinout Dietary Assessment Ltd. Maombi ya kutumia myfood24 yanapaswa kufanywa kwa enquiries@myfood24.org.
   </p>
  </ack>
  <sec sec-type="author-contribution">
   <title>
    Mchango wa waandishi
   </title>
   <p>
    M.N.L., K.W. na C.J.S. walibuni utafiti na kuandika itifaki kwa ushirikiano kutoka kwa R.C.E.B., M.P.G, S.W., A.F.B, A.N., A.S., G.A., D.H., C.M., S.D.R.H., A.A.W. na C.G., A.N., A.S., G.A., D.H. na C.M. waliunga mkono jaribio la kliniki, ikiwa ni pamoja na uandikishaji na/au usimamizi wa wagonjwa katika jaribio. M.N.L. alifanya uchambuzi wa takwimu kwa ushirikiano kutoka kwa C.J.S, K.W. R.C.E.B, P.T.S. na G.R. J.M.M. alifanya uchambuzi wa microbiome kwa ushirikiano kutoka kwa M.N.L., C.J.S. na R.C.E.B. M.N.L., S.W., A.F.B, A.N. na A.S. walisaidia kukusanya data na sampuli. M.N.L. aliandika karatasi. Waandishi wote walipitia karatasi na kuidhinisha toleo la mwisho.
   </p>
  </sec>
  <sec sec-type="peer-review">
   <title>
    Mapitio ya rika
   </title>
   <sec id="FPar1">
    <title>
     Taarifa za mapitio ya rika
    </title>
    <p id="Par70">
     <italic>
      Nature Communications
     </italic>
     thanks Edward Chambers, Ali Keshavarzian and Huang Lin for their contribution to the peer review of this work. A peer review file is available.
    </p>
   </sec>
  </sec>
  <sec sec-type="data-availability">
   <title>
    Upatikanaji wa data
   </title>
   <p>
    The gut microbiome sequencing data generated in this study have been deposited in the European Nucleotide Archive (ENA) at EMBL-EBI under accession number
    <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/browser/view/PRJEB72531">
     PRJEB72531
    </ext-link>
    . All other data are available on request from TwinsUK, and access can be obtained after approval by the TwinsUK Resource Executive Committee by following this link:
    <ext-link ext-link-type="uri" xlink:href="https://twinsuk.ac.uk/resources-for-researchers/access-our-data/">
     https://twinsuk.ac.uk/resources-for-researchers/access-our-data/
    </ext-link>
    .
   </p>
  </sec>
  <sec sec-type="data-availability">
   <title>
    Upatikanaji wa msimbo
   </title>
   <p>
    Stata code was utilised for data cleaning and analysis using Stata SE version 15.1
    <sup>
     <xref ref-type="bibr" rid="CR84">
      84
     </xref>
    </sup>
    . Gut microbiome analysis utilised R version 4.2.1
    <sup>
     <xref ref-type="bibr" rid="CR85">
      85
     </xref>
    </sup>
    , using R packages vegan (available from:
    <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/vegan/index.html">
     https://cran.r-project.org/web/packages/vegan/index.html
    </ext-link>
    ) and Mets (available from
    <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/mets/index.html">
     https://cran.r-project.org/web/packages/mets/index.html
    </ext-link>
    ).
   </p>
  </sec>
  <sec sec-type="ethics-statement">
   <sec id="FPar2" sec-type="COI-statement">
    <title>
     Maslahi yanayokinzana
    </title>
    <p id="Par71">
     C.J.S. has consulted for Zoe Limited for work on the Zoe Health Study. Janne Marie Moll is an employee of Clinical Microbiomics. K.W. is a co-inventor/patent holder for volatile organic compounds in the diagnosis and management of irritable bowel syndrome. The remaining authors declare no competing interests.
    </p>
   </sec>
   <sec id="FPar3">
    <title>
     Idhini ya kimaadili
    </title>
    <p id="Par72">
     The PROMOTe Study was approved by NHS North of Scotland Research Ethics Service (REC reference 21/NS/0045), IRAS ID 257415. This study was carried out under TwinsUK BioBank ethics, approved by North West—Liverpool Central Research Ethics Committee (REC reference 19/NW/0187), IRAS ID 258513. This approval supersedes earlier approvals granted to TwinsUK by the St Thomas’ Hospital Research Ethics Committee, later London—Westminster Research Ethics Committee (REC reference EC04/015), which have now been subsumed within the TwinsUK BioBank. Written informed consent was obtained from all participants. All research, therefore carried out in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
    </p>
   </sec>
  </sec>
  <ref-list id="Bib1">
   <title>
    Marejeleo
   </title>
   <ref-list>
    <ref id="CR1">
     <label>
      1.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kingston
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Is late-life dependency increasing or not? A comparison of the Cognitive Function and Ageing Studies (CFAS)
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       2017
      </year>
      <volume>
       390
      </volume>
      <fpage>
       1676
      </fpage>
      <lpage>
       1684
      </lpage>
      <pub-id pub-id-type="pmid">
       28821408
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5640505
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(17)31575-1
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR2">
     <label>
      2.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Arvanitakis
        </surname>
        <given-names>
         Z
        </given-names>
       </name>
       <name>
        <surname>
         Shah
        </surname>
        <given-names>
         RC
        </given-names>
       </name>
       <name>
        <surname>
         Bennett
        </surname>
        <given-names>
         DA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Diagnosis and management of dementia: review
      </article-title>
      <source>
       J. Am. Med. Assoc.
      </source>
      <year>
       2019
      </year>
      <volume>
       322
      </volume>
      <fpage>
       1589
      </fpage>
      <pub-id pub-id-type="doi">
       10.1001/jama.2019.4782
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR3">
     <label>
      3.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Harada
        </surname>
        <given-names>
         CN
        </given-names>
       </name>
       <name>
        <surname>
         Natelson Love
        </surname>
        <given-names>
         MC
        </given-names>
       </name>
       <name>
        <surname>
         Triebel
        </surname>
        <given-names>
         KL
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Normal cognitive aging
      </article-title>
      <source>
       Clin. Geriatr. Med.
      </source>
      <year>
       2013
      </year>
      <volume>
       29
      </volume>
      <fpage>
       737
      </fpage>
      <lpage>
       752
      </lpage>
      <pub-id pub-id-type="pmid">
       24094294
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4015335
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cger.2013.07.002
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR4">
     <label>
      4.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sayer
        </surname>
        <given-names>
         AA
        </given-names>
       </name>
       <name>
        <surname>
         Cruz-Jentoft
        </surname>
        <given-names>
         A
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Sarcopenia definition, diagnosis and treatment: consensus is growing
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2022
      </year>
      <volume>
       51
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       5
      </lpage>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afac220
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR5">
     <label>
      5.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mandolesi
        </surname>
        <given-names>
         L
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effects of physical exercise on cognitive functioning and wellbeing: biological and psychological benefits
      </article-title>
      <source>
       Front. Psychol.
      </source>
      <year>
       2018
      </year>
      <volume>
       9
      </volume>
      <fpage>
       509
      </fpage>
      <pub-id pub-id-type="pmid">
       29755380
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5934999
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fpsyg.2018.00509
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR6">
     <label>
      6.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Bowyer
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Steves
        </surname>
        <given-names>
         C
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Dietary protein and muscle in aging people: the potential role of the gut microbiome
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2018
      </year>
      <volume>
       10
      </volume>
      <fpage>
       929
      </fpage>
      <pub-id pub-id-type="pmid">
       30036990
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6073774
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu10070929
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR7">
     <label>
      7.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Welch
        </surname>
        <given-names>
         AA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Nutritional influences on age-related skeletal muscle loss
      </article-title>
      <source>
       Proc. Nutr. Soc.
      </source>
      <year>
       2014
      </year>
      <volume>
       73
      </volume>
      <fpage>
       16
      </fpage>
      <lpage>
       33
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXitFylsL4%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24229650
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S0029665113003698
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR8">
     <label>
      8.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Deutz
        </surname>
        <given-names>
         NEP
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group
      </article-title>
      <source>
       Clin. Nutr.
      </source>
      <year>
       2014
      </year>
      <volume>
       33
      </volume>
      <fpage>
       929
      </fpage>
      <lpage>
       936
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXnslehtL0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24814383
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4208946
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.clnu.2014.04.007
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR9">
     <label>
      9.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cermak
        </surname>
        <given-names>
         NM
        </given-names>
       </name>
       <name>
        <surname>
         Res
        </surname>
        <given-names>
         PT
        </given-names>
       </name>
       <name>
        <surname>
         de Groot
        </surname>
        <given-names>
         LC
        </given-names>
       </name>
       <name>
        <surname>
         Saris
        </surname>
        <given-names>
         WHM
        </given-names>
       </name>
       <name>
        <surname>
         van Loon
        </surname>
        <given-names>
         LJ
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2012
      </year>
      <volume>
       96
      </volume>
      <fpage>
       1454
      </fpage>
      <lpage>
       1464
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38XhslylsbfF
      </pub-id>
      <pub-id pub-id-type="pmid">
       23134885
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.112.037556
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR10">
     <label>
      10.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Daly
        </surname>
        <given-names>
         RM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Does lean red meat enhance the effetcs of exercise on muscle health and function in the elderly?
       <italic>
        Innov
       </italic>
      </article-title>
      <source>
       Aging
      </source>
      <year>
       2017
      </year>
      <volume>
       1
      </volume>
      <fpage>
       3
      </fpage>
      <lpage>
       4
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR11">
     <label>
      11.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Daly
        </surname>
        <given-names>
         RM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Protein-enriched diet, with the use of lean red meat, combined with progressive resistance training enhances lean tissue mass and muscle strength and reduces circulating IL-6 concentrations in elderly women: a cluster randomized controlled trial
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2014
      </year>
      <volume>
       99
      </volume>
      <fpage>
       899
      </fpage>
      <lpage>
       910
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXls1Oiur0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24477043
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.113.064154
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR12">
     <label>
      12.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Marchesi
        </surname>
        <given-names>
         JR
        </given-names>
       </name>
       <name>
        <surname>
         Ravel
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The vocabulary of microbiome research: a proposal
      </article-title>
      <source>
       Microbiome
      </source>
      <year>
       2015
      </year>
      <volume>
       3
      </volume>
      <pub-id pub-id-type="pmid">
       26229597
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4520061
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s40168-015-0094-5
      </pub-id>
      <elocation-id>
       31
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR13">
     <label>
      13.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Biagi
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2010
      </year>
      <volume>
       5
      </volume>
      <fpage>
       e10667
      </fpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2010PLoSO...510667B
      </pub-id>
      <pub-id pub-id-type="pmid">
       20498852
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2871786
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0010667
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR14">
     <label>
      14.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Grosicki
        </surname>
        <given-names>
         GJ
        </given-names>
       </name>
       <name>
        <surname>
         Fielding
        </surname>
        <given-names>
         RA
        </given-names>
       </name>
       <name>
        <surname>
         Lustgarten
        </surname>
        <given-names>
         MS
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota contribute to age-related changes in skeletal muscle size, composition, and function: biological basis for a gut-muscle axis
      </article-title>
      <source>
       Calcif. Tissue Int.
      </source>
      <year>
       2018
      </year>
      <volume>
       102
      </volume>
      <fpage>
       433
      </fpage>
      <lpage>
       442
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhslWjurrJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       29058056
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00223-017-0345-5
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR15">
     <label>
      15.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ticinesi
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: is there a gut-muscle axis?
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2017
      </year>
      <volume>
       9
      </volume>
      <fpage>
       1303
      </fpage>
      <pub-id pub-id-type="pmid">
       29189738
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5748753
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu9121303
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR16">
     <label>
      16.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ticinesi
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients
      </article-title>
      <source>
       Sci. Rep.
      </source>
      <year>
       2017
      </year>
      <volume>
       7
      </volume>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2017NatSR...711102T
      </pub-id>
      <pub-id pub-id-type="pmid">
       28894183
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5593887
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41598-017-10734-y
      </pub-id>
      <elocation-id>
       11102
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR17">
     <label>
      17.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ridaura
        </surname>
        <given-names>
         VK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota from twins discordant for obesity modulate metabolism in mice
      </article-title>
      <source>
       Science (1979)
      </source>
      <year>
       2013
      </year>
      <volume>
       341
      </volume>
      <fpage>
       1241214
      </fpage>
     </mixed-citation>
    </ref>
    <ref id="CR18">
     <label>
      18.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Prokopidis
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <name>
        <surname>
         Chambers
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Witard
        </surname>
        <given-names>
         OC
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mechanisms linking the gut-muscle axis with muscle protein metabolism and anabolic resistance: implications for older adults at risk of sarcopenia
      </article-title>
      <source>
       Front. Physiol.
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       1910
      </fpage>
      <pub-id pub-id-type="doi">
       10.3389/fphys.2021.770455
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR19">
     <label>
      19.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Raj
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Dileep
        </surname>
        <given-names>
         U
        </given-names>
       </name>
       <name>
        <surname>
         Vaz
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Fuller
        </surname>
        <given-names>
         MF
        </given-names>
       </name>
       <name>
        <surname>
         Kurpad
        </surname>
        <given-names>
         AV
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Intestinal microbial contribution to metabolic leucine input in adult men
      </article-title>
      <source>
       J. Nutr.
      </source>
      <year>
       2008
      </year>
      <volume>
       138
      </volume>
      <fpage>
       2217
      </fpage>
      <lpage>
       2221
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1cXht1ymtr7J
      </pub-id>
      <pub-id pub-id-type="pmid">
       18936222
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/jn.108.093021
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR20">
     <label>
      20.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zhang
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Cheng
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <name>
        <surname>
         Hu
        </surname>
        <given-names>
         YM
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota as a promising therapeutic target for age-related sarcopenia
      </article-title>
      <source>
       Ageing Res. Rev.
      </source>
      <year>
       2022
      </year>
      <volume>
       81
      </volume>
      <fpage>
       101739
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38Xis1aisr%2FN
      </pub-id>
      <pub-id pub-id-type="pmid">
       36182084
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.arr.2022.101739
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR21">
     <label>
      21.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         de Marco Castro
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Murphy
        </surname>
        <given-names>
         CH
        </given-names>
       </name>
       <name>
        <surname>
         Roche
        </surname>
        <given-names>
         HM
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Targeting the gut microbiota to improve dietary protein efficacy to mitigate sarcopenia
      </article-title>
      <source>
       Front. Nutr.
      </source>
      <year>
       2021
      </year>
      <volume>
       8
      </volume>
      <fpage>
       656730
      </fpage>
      <pub-id pub-id-type="pmid">
       34235167
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8256992
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fnut.2021.656730
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR22">
     <label>
      22.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lahiri
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The gut microbiota influences skeletal muscle mass and function in mice
      </article-title>
      <source>
       Sci. Transl. Med.
      </source>
      <year>
       2019
      </year>
      <volume>
       11
      </volume>
      <fpage>
       eaan5662
      </fpage>
      <pub-id pub-id-type="pmid">
       31341063
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7501733
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1126/scitranslmed.aan5662
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR23">
     <label>
      23.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Manickam
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Oh
        </surname>
        <given-names>
         HYP
        </given-names>
       </name>
       <name>
        <surname>
         Tan
        </surname>
        <given-names>
         CK
        </given-names>
       </name>
       <name>
        <surname>
         Paramalingam
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Wahli
        </surname>
        <given-names>
         W
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Metronidazole causes skeletal muscle atrophy and modulates muscle chronometabolism
      </article-title>
      <source>
       Int. J. Mol. Sci.
      </source>
      <year>
       2018
      </year>
      <volume>
       19
      </volume>
      <fpage>
       2418
      </fpage>
      <pub-id pub-id-type="pmid">
       30115857
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6121908
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/ijms19082418
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR24">
     <label>
      24.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         GR
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The International Scientific Association for Probiotics and Prebiotics (ISAPP) Consensus statement on the definition and scope of prebiotics
      </article-title>
      <source>
       Nat. Rev. Gastroenterol. Hepatol.
      </source>
      <year>
       2017
      </year>
      <volume>
       14
      </volume>
      <fpage>
       491
      </fpage>
      <lpage>
       502
      </lpage>
      <pub-id pub-id-type="pmid">
       28611480
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nrgastro.2017.75
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR25">
     <label>
      25.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Buigues
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effect of a prebiotic formulation on frailty syndrome: a randomized, double-blind clinical trial
      </article-title>
      <source>
       Int. J. Mol. Sci.
      </source>
      <year>
       2016
      </year>
      <volume>
       17
      </volume>
      <fpage>
       932
      </fpage>
      <pub-id pub-id-type="pmid">
       27314331
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4926465
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/ijms17060932
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR26">
     <label>
      26.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Theou
        </surname>
        <given-names>
         O
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Can a prebiotic formulation reduce frailty levels in older people?
      </article-title>
      <source>
       J. Frailty Aging
      </source>
      <year>
       2018
      </year>
      <volume>
       8
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       5
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR27">
     <label>
      27.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Desmedt
        </surname>
        <given-names>
         O
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effects of prebiotics on affect and cognition in human intervention studies
      </article-title>
      <source>
       Nutr. Rev.
      </source>
      <year>
       2019
      </year>
      <volume>
       77
      </volume>
      <fpage>
       81
      </fpage>
      <lpage>
       95
      </lpage>
      <pub-id pub-id-type="pmid">
       30535275
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/nutrit/nuy052
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR28">
     <label>
      28.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cox
        </surname>
        <given-names>
         NJ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The composition of the gut microbiome differs among community dwelling older people with good and poor appetite
      </article-title>
      <source>
       J. Cachexia Sarcopenia Muscle
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       368
      </fpage>
      <lpage>
       377
      </lpage>
      <pub-id pub-id-type="pmid">
       33580637
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8061352
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/jcsm.12683
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR29">
     <label>
      29.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Guess
        </surname>
        <given-names>
         ND
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A randomized controlled trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes
      </article-title>
      <source>
       Nutr. Metab. (Lond.)
      </source>
      <year>
       2015
      </year>
      <volume>
       12
      </volume>
      <fpage>
       36
      </fpage>
      <pub-id pub-id-type="pmid">
       26500686
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12986-015-0033-2
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR30">
     <label>
      30.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Liber
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Szajewska
        </surname>
        <given-names>
         H
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Effects of inulin-type fructans on appetite, energy intake, and body weight in children and adults: systematic review of randomized controlled trials
      </article-title>
      <source>
       Ann. Nutr. Metab.
      </source>
      <year>
       2013
      </year>
      <volume>
       63
      </volume>
      <fpage>
       42
      </fpage>
      <lpage>
       54
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhsF2rsL7L
      </pub-id>
      <pub-id pub-id-type="pmid">
       23887189
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1159/000350312
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR31">
     <label>
      31.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Baker
        </surname>
        <given-names>
         JE
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Visual paired associate learning deficits associated with elevated beta-amyloid in cognitively normal older adults
      </article-title>
      <source>
       Neuropsychology
      </source>
      <year>
       2019
      </year>
      <volume>
       33
      </volume>
      <fpage>
       964
      </fpage>
      <lpage>
       974
      </lpage>
      <pub-id pub-id-type="pmid">
       31368758
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1037/neu0000561
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR32">
     <label>
      32.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Hicks
        </surname>
        <given-names>
         EB
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Associations of visual paired associative learning task with global cognition and its potential usefulness as a screening tool for Alzheimer’s Dementia
      </article-title>
      <source>
       Int. Psychogeriatr.
      </source>
      <year>
       2021
      </year>
      <volume>
       33
      </volume>
      <fpage>
       1135
      </fpage>
      <lpage>
       1144
      </lpage>
      <pub-id pub-id-type="pmid">
       33336635
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S1041610220003841
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR33">
     <label>
      33.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Vulevic
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Drakoularakou
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Yaqoob
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Tzortzis
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         GR
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2008
      </year>
      <volume>
       88
      </volume>
      <fpage>
       1438
      </fpage>
      <lpage>
       1484
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1cXhtlOqu7vP
      </pub-id>
      <pub-id pub-id-type="pmid">
       18996881
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.2008.26242
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR34">
     <label>
      34.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Bergquist
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Performance-based clinical tests of balance and muscle strength used in young seniors: a systematic literature review
      </article-title>
      <source>
       BMC Geriatr.
      </source>
      <year>
       2019
      </year>
      <volume>
       19
      </volume>
      <fpage>
       9
      </fpage>
      <pub-id pub-id-type="pmid">
       30626340
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6327480
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12877-018-1011-0
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR35">
     <label>
      35.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Harvey
        </surname>
        <given-names>
         NC
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Measures of physical performance and muscle strength as predictors of fracture risk independent of FRAX, Falls, and aBMD: a meta-analysis of the osteoporotic fractures in men (MrOS) study
      </article-title>
      <source>
       J. Bone Miner. Res.
      </source>
      <year>
       2018
      </year>
      <volume>
       33
      </volume>
      <fpage>
       2150
      </fpage>
      <lpage>
       2157
      </lpage>
      <pub-id pub-id-type="pmid">
       30011086
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/jbmr.3556
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR36">
     <label>
      36.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Walker
        </surname>
        <given-names>
         SN
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Maintenance of activity and eating change after a clinical trial of tailored newsletters with older rural women
      </article-title>
      <source>
       Nurs. Res.
      </source>
      <year>
       2010
      </year>
      <volume>
       59
      </volume>
      <fpage>
       311
      </fpage>
      <lpage>
       321
      </lpage>
      <pub-id pub-id-type="pmid">
       20697307
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2963620
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1097/NNR.0b013e3181ed6695
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR37">
     <label>
      37.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cesari
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Added value of physical performance measures in predicting adverse health-related events: results from the health, aging, and body composition study
      </article-title>
      <source>
       J. Am. Geriatr. Soc.
      </source>
      <year>
       2009
      </year>
      <volume>
       57
      </volume>
      <fpage>
       251
      </fpage>
      <lpage>
       259
      </lpage>
      <pub-id pub-id-type="pmid">
       19207142
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2695653
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/j.1532-5415.2008.02126.x
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR38">
     <label>
      38.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tandon
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora
      </article-title>
      <source>
       Sci. Rep.
      </source>
      <year>
       2019
      </year>
      <volume>
       9
      </volume>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2019NatSR...9.5473T
      </pub-id>
      <pub-id pub-id-type="pmid">
       30940833
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6445088
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41598-019-41837-3
      </pub-id>
      <elocation-id>
       5473
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR39">
     <label>
      39.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         So
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2018
      </year>
      <volume>
       107
      </volume>
      <fpage>
       965
      </fpage>
      <lpage>
       983
      </lpage>
      <pub-id pub-id-type="pmid">
       29757343
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ajcn/nqy041
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR40">
     <label>
      40.
     </label>
     <mixed-citation publication-type="other">
      Cognitive Tests | Cambridge Cognition.
      <ext-link ext-link-type="uri" xlink:href="https://www.cambridgecognition.com/cantab/cognitive-tests/">
       https://www.cambridgecognition.com/cantab/cognitive-tests/
      </ext-link>
      .
     </mixed-citation>
    </ref>
    <ref id="CR41">
     <label>
      41.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cryan
        </surname>
        <given-names>
         JF
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The microbiota-gut-brain axis
      </article-title>
      <source>
       Physiol. Rev.
      </source>
      <year>
       2019
      </year>
      <volume>
       99
      </volume>
      <fpage>
       1877
      </fpage>
      <lpage>
       2013
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXitFWjsLs%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       31460832
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1152/physrev.00018.2018
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR42">
     <label>
      42.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Jenkins
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Nguyen
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Polglaze
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <name>
        <surname>
         Bertrand
        </surname>
        <given-names>
         P
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2016
      </year>
      <volume>
       8
      </volume>
      <fpage>
       56
      </fpage>
      <pub-id pub-id-type="pmid">
       26805875
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4728667
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu8010056
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR43">
     <label>
      43.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Grenham
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Clarke
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Cryan
        </surname>
        <given-names>
         JF
        </given-names>
       </name>
       <name>
        <surname>
         Dinan
        </surname>
        <given-names>
         TG
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Brain-gut-microbe communication in health and disease
      </article-title>
      <source>
       Front. Physiol.
      </source>
      <year>
       2011
      </year>
      <volume>
       2
      </volume>
      <fpage>
       94
      </fpage>
      <pub-id pub-id-type="pmid">
       22162969
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3232439
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fphys.2011.00094
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR44">
     <label>
      44.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gaman
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Kuo
        </surname>
        <given-names>
         B
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Neuromodulatory processes of the brain–gut axis
      </article-title>
      <source>
       Neuromodulation
      </source>
      <year>
       2008
      </year>
      <volume>
       11
      </volume>
      <fpage>
       249
      </fpage>
      <lpage>
       259
      </lpage>
      <pub-id pub-id-type="pmid">
       19844605
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2763396
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/j.1525-1403.2008.00172.x
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR45">
     <label>
      45.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tran
        </surname>
        <given-names>
         TTT
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Prebiotic supplementation in frail older people affects specific gut microbiota taxa but not global diversity
      </article-title>
      <source>
       Microbiome
      </source>
      <year>
       2019
      </year>
      <volume>
       7
      </volume>
      <pub-id pub-id-type="pmid">
       30867067
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6417215
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s40168-019-0654-1
      </pub-id>
      <elocation-id>
       39
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR46">
     <label>
      46.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lancaster
        </surname>
        <given-names>
         SM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Global, distinctive, and personal changes in molecular and microbial profiles by specific fibers in humans
      </article-title>
      <source>
       Cell Host Microbe
      </source>
      <year>
       2022
      </year>
      <volume>
       30
      </volume>
      <fpage>
       848
      </fpage>
      <lpage>
       862.e7
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XhtFejtbvE
      </pub-id>
      <pub-id pub-id-type="pmid">
       35483363
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9187607
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.chom.2022.03.036
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR47">
     <label>
      47.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Healey
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study
      </article-title>
      <source>
       Br. J. Nutr.
      </source>
      <year>
       2018
      </year>
      <volume>
       119
      </volume>
      <fpage>
       176
      </fpage>
      <lpage>
       189
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXhsVarsrg%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       29307330
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S0007114517003440
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR48">
     <label>
      48.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Le Bastard
        </surname>
        <given-names>
         Q
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The effects of inulin on gut microbial composition: a systematic review of evidence from human studies
      </article-title>
      <source>
       Eur. J. Clin. Microbiol. Infect. Dis.
      </source>
      <year>
       2020
      </year>
      <volume>
       39
      </volume>
      <fpage>
       403
      </fpage>
      <lpage>
       413
      </lpage>
      <pub-id pub-id-type="pmid">
       31707507
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s10096-019-03721-w
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR49">
     <label>
      49.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Watson
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Selective carbohydrate utilization by lactobacilli and bifidobacteria
      </article-title>
      <source>
       J. Appl. Microbiol.
      </source>
      <year>
       2013
      </year>
      <volume>
       114
      </volume>
      <fpage>
       1132
      </fpage>
      <lpage>
       1146
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXkt1Kiu7o%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       23240984
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/jam.12105
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR50">
     <label>
      50.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wilson
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <name>
        <surname>
         Rossi
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Dimidi
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Whelan
        </surname>
        <given-names>
         K
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2019
      </year>
      <volume>
       109
      </volume>
      <fpage>
       1098
      </fpage>
      <lpage>
       1111
      </lpage>
      <pub-id pub-id-type="pmid">
       30949662
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ajcn/nqy376
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR51">
     <label>
      51.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cherbut
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Michel
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Lecannu
        </surname>
        <given-names>
         G
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats
      </article-title>
      <source>
       J. Nutr.
      </source>
      <year>
       2003
      </year>
      <volume>
       133
      </volume>
      <fpage>
       21
      </fpage>
      <lpage>
       27
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD3sXjslejtg%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       12514261
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/jn/133.1.21
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR52">
     <label>
      52.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodrich
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Genetic determinants of the gut microbiome in UK twins
      </article-title>
      <source>
       Cell Host Microbe
      </source>
      <year>
       2016
      </year>
      <volume>
       19
      </volume>
      <fpage>
       731
      </fpage>
      <lpage>
       743
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XntlShtbo%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27173935
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4915943
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.chom.2016.04.017
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR53">
     <label>
      53.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodrich
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Human genetics shape the gut microbiome
      </article-title>
      <source>
       Cell
      </source>
      <year>
       2014
      </year>
      <volume>
       159
      </volume>
      <fpage>
       789
      </fpage>
      <lpage>
       799
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhvV2msrnJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       25417156
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4255478
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cell.2014.09.053
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR54">
     <label>
      54.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Yang
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Unfavourable intrauterine environment contributes to abnormal gut microbiome and metabolome in twins
      </article-title>
      <source>
       Gut
      </source>
      <year>
       2022
      </year>
      <volume>
       71
      </volume>
      <fpage>
       2451
      </fpage>
      <lpage>
       2462
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XivFegtb3P
      </pub-id>
      <pub-id pub-id-type="pmid">
       35387876
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1136/gutjnl-2021-326482
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR55">
     <label>
      55.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Xie
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Shotgun metagenomics of 250 adult twins reveals genetic and environmental impacts on the gut microbiome
      </article-title>
      <source>
       Cell Syst.
      </source>
      <year>
       2016
      </year>
      <volume>
       3
      </volume>
      <fpage>
       572
      </fpage>
      <lpage>
       584.e3
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhtFalsLw%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27818083
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6309625
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cels.2016.10.004
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR56">
     <label>
      56.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Stincone
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
      </article-title>
      <source>
       Biol. Rev.
      </source>
      <year>
       2015
      </year>
      <volume>
       90
      </volume>
      <fpage>
       927
      </fpage>
      <lpage>
       963
      </lpage>
      <pub-id pub-id-type="pmid">
       25243985
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/brv.12140
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR57">
     <label>
      57.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wagner
        </surname>
        <given-names>
         KR
        </given-names>
       </name>
       <name>
        <surname>
         Kauffman
        </surname>
        <given-names>
         FC
        </given-names>
       </name>
       <name>
        <surname>
         Max
        </surname>
        <given-names>
         SR
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The pentose phosphate pathway in regenerating skeletal muscle
      </article-title>
      <source>
       Biochem. J.
      </source>
      <year>
       1978
      </year>
      <volume>
       170
      </volume>
      <fpage>
       17
      </fpage>
      <lpage>
       22
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DyaE1cXhsV2ks7Y%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       629775
      </pub-id>
      <pub-id pub-id-type="pmcid">
       1183856
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1042/bj1700017
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR58">
     <label>
      58.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Valentino
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Figueiredo
        </surname>
        <given-names>
         VC
        </given-names>
       </name>
       <name>
        <surname>
         Mobley
        </surname>
        <given-names>
         CB
        </given-names>
       </name>
       <name>
        <surname>
         McCarthy
        </surname>
        <given-names>
         JJ
        </given-names>
       </name>
       <name>
        <surname>
         Vechetti
        </surname>
        <given-names>
         IJ
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Evidence of myomiR regulation of the pentose phosphate pathway during mechanical load‐induced hypertrophy
      </article-title>
      <source>
       Physiol. Rep.
      </source>
      <year>
       2021
      </year>
      <volume>
       9
      </volume>
      <fpage>
       15137
      </fpage>
      <pub-id pub-id-type="doi">
       10.14814/phy2.15137
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR59">
     <label>
      59.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Carabotti
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Scirocco
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Maselli
        </surname>
        <given-names>
         MA
        </given-names>
       </name>
       <name>
        <surname>
         Severi
        </surname>
        <given-names>
         C
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems
      </article-title>
      <source>
       Ann. Gastroenterol.
      </source>
      <year>
       2015
      </year>
      <volume>
       28
      </volume>
      <fpage>
       203
      </fpage>
      <pub-id pub-id-type="pmid">
       25830558
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4367209
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR60">
     <label>
      60.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Connell
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
      </article-title>
      <source>
       Mol. Neurodegener.
      </source>
      <year>
       2022
      </year>
      <volume>
       17
      </volume>
      <fpage>
       43
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XitVeqt7bF
      </pub-id>
      <pub-id pub-id-type="pmid">
       35715821
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9204954
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13024-022-00548-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR61">
     <label>
      61.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Jeong
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Cognitive function associated with gut microbial abundance in sucrose and S-adenosyl-L-methionine (SAMe) metabolic pathways
      </article-title>
      <source>
       J. Alzheimer’s Dis.
      </source>
      <year>
       2022
      </year>
      <volume>
       87
      </volume>
      <fpage>
       1115
      </fpage>
      <lpage>
       1130
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38Xhtl2lurvK
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3233/JAD-215090
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR62">
     <label>
      62.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         Z
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Altered actinobacteria and firmicutes phylum associated epitopes in patients with Parkinson’s disease
      </article-title>
      <source>
       Front. Immunol.
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       2541
      </fpage>
     </mixed-citation>
    </ref>
    <ref id="CR63">
     <label>
      63.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Fernandez-Real
        </surname>
        <given-names>
         J-M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota interacts with brain microstructure and function
      </article-title>
      <source>
       J. Clin. Endocrinol. Metab.
      </source>
      <year>
       2015
      </year>
      <volume>
       100
      </volume>
      <fpage>
       4505
      </fpage>
      <lpage>
       4513
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XjtlSntr0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       26445114
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1210/jc.2015-3076
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR64">
     <label>
      64.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tooley
        </surname>
        <given-names>
         KL
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Effects of the human gut microbiota on cognitive performance, brain structure and function: a narrative review
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2020
      </year>
      <volume>
       12
      </volume>
      <fpage>
       3009
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXitlyjur3K
      </pub-id>
      <pub-id pub-id-type="pmid">
       33007941
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7601389
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu12103009
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR65">
     <label>
      65.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Witham
        </surname>
        <given-names>
         MD
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process
      </article-title>
      <source>
       Trials
      </source>
      <year>
       2020
      </year>
      <volume>
       21
      </volume>
      <pub-id pub-id-type="pmid">
       32738919
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7395975
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13063-020-04613-7
      </pub-id>
      <elocation-id>
       694
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR66">
     <label>
      66.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodwin
        </surname>
        <given-names>
         VA
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       INCLUDE older people: best practice recommendations in health and social care research
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2023
      </year>
      <volume>
       52
      </volume>
      <fpage>
       afad082
      </fpage>
      <pub-id pub-id-type="pmid">
       37261448
      </pub-id>
      <pub-id pub-id-type="pmcid">
       10234283
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afad082
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR67">
     <label>
      67.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cruz-Jentoft
        </surname>
        <given-names>
         AJ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Sarcopenia: revised European consensus on definition and diagnosis
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2019
      </year>
      <volume>
       48
      </volume>
      <fpage>
       601
      </fpage>
      <lpage>
       601
      </lpage>
      <pub-id pub-id-type="pmid">
       31081853
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6593317
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afz046
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR68">
     <label>
      68.
     </label>
     <mixed-citation publication-type="other">
      Verdi, S. et al. TwinsUK: The UK Adult Twin Registry Update.
      <italic>
       Twin Res. Hum. Genetics
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.1017/thg.2019.65">
       https://doi.org/10.1017/thg.2019.65
      </ext-link>
      (2019).
     </mixed-citation>
    </ref>
    <ref id="CR69">
     <label>
      69.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The PROMOTe study: targeting the gut microbiome with prebiotics to overcome age-related anabolic resistance: protocol for a double-blinded, randomised, placebo-controlled trial
      </article-title>
      <source>
       BMC Geriatr.
      </source>
      <year>
       2021
      </year>
      <volume>
       21
      </volume>
      <fpage>
       407
      </fpage>
      <pub-id pub-id-type="pmid">
       34210274
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8248289
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12877-021-02301-y
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR70">
     <label>
      70.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Masoli
        </surname>
        <given-names>
         JAH
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyond
      </article-title>
      <source>
       Trials
      </source>
      <year>
       2021
      </year>
      <volume>
       22
      </volume>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3MXislajt73K
      </pub-id>
      <pub-id pub-id-type="pmid">
       34895305
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8665850
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13063-021-05880-8
      </pub-id>
      <elocation-id>
       911
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR71">
     <label>
      71.
     </label>
     <mixed-citation publication-type="other">
      Office for National Statistics. Internet users UK 2020.
      <ext-link ext-link-type="uri" xlink:href="https://www.ons.gov.uk/businessindustryandtrade/itandinternetindustry/bulletins/internetusers/2020">
       https://www.ons.gov.uk/businessindustryandtrade/itandinternetindustry/bulletins/internetusers/2020
      </ext-link>
      (2020).
     </mixed-citation>
    </ref>
    <ref id="CR72">
     <label>
      72.
     </label>
     <mixed-citation publication-type="other">
      Doody, P. et al.
      <italic>
       Internet access and use among adults aged 50 and over in Ireland: Results from Wave 5 of The Irish Longitudinal Study on Ageing
      </italic>
      .
      <italic>
       The Irish Longitudinal Study on Ageing
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.38018/TildaRe.2020-06">
       https://doi.org/10.38018/TildaRe.2020-06
      </ext-link>
      (2020).
     </mixed-citation>
    </ref>
    <ref id="CR73">
     <label>
      73.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Carter
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Development of a UK Online 24-h Dietary Assessment Tool: myfood24
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2015
      </year>
      <volume>
       7
      </volume>
      <fpage>
       4016
      </fpage>
      <lpage>
       4032
      </lpage>
      <pub-id pub-id-type="pmid">
       26024292
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4488770
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu7064016
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR74">
     <label>
      74.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Threapleton
        </surname>
        <given-names>
         DE
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Usability of myfood24 healthcare and mathematical diet optimisation in clinical populations: a pilot feasibility randomised controlled trial
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2022
      </year>
      <volume>
       14
      </volume>
      <fpage>
       1768
      </fpage>
      <pub-id pub-id-type="pmid">
       35565736
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9101756
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu14091768
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR75">
     <label>
      75.
     </label>
     <mixed-citation publication-type="other">
      Strength exercises—NHS.
      <ext-link ext-link-type="uri" xlink:href="https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/">
       https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/
      </ext-link>
      .
     </mixed-citation>
    </ref>
    <ref id="CR76">
     <label>
      76.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Millor
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <name>
        <surname>
         Lecumberri
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Gómez
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Martínez-Ramírez
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Izquierdo
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       An evaluation of the 30-s chair stand test in older adults: frailty detection based on kinematic parameters from a single inertial unit
      </article-title>
      <source>
       J. Neuroeng. Rehabil.
      </source>
      <year>
       2013
      </year>
      <volume>
       10
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       9
      </lpage>
      <pub-id pub-id-type="doi">
       10.1186/1743-0003-10-86
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR77">
     <label>
      77.
     </label>
     <mixed-citation publication-type="other">
      Dodds, R. M. et al. Prevalence and factors associated with poor performance in the 5‐chair stand test: findings from the Cognitive Function and Ageing Study II and proposed Newcastle protocol for use in the assessment of sarcopenia.
      <italic>
       J. Cachexia Sarcopenia Muscle
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.1002/jcsm.12660">
       https://doi.org/10.1002/jcsm.12660
      </ext-link>
      (2021).
     </mixed-citation>
    </ref>
    <ref id="CR78">
     <label>
      78.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Durbin
        </surname>
        <given-names>
         R
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Fast and accurate short read alignment with Burrows–Wheeler transform
      </article-title>
      <source>
       Bioinformatics
      </source>
      <year>
       2009
      </year>
      <volume>
       25
      </volume>
      <fpage>
       1754
      </fpage>
      <lpage>
       1760
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1MXot1Cjtbo%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       19451168
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2705234
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/bioinformatics/btp324
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR79">
     <label>
      79.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Huerta-Cepas
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Fast genome-wide functional annotation through orthology assignment by eggNOG-Mapper
      </article-title>
      <source>
       Mol. Biol. Evol.
      </source>
      <year>
       2017
      </year>
      <volume>
       34
      </volume>
      <fpage>
       2115
      </fpage>
      <lpage>
       2122
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXhvFaru7vF
      </pub-id>
      <pub-id pub-id-type="pmid">
       28460117
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5850834
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/molbev/msx148
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR80">
     <label>
      80.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kanehisa
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       KEGG: Kyoto Encyclopedia of Genes and Genomes
      </article-title>
      <source>
       Nucleic Acids Res.
      </source>
      <year>
       2000
      </year>
      <volume>
       28
      </volume>
      <fpage>
       27
      </fpage>
      <lpage>
       30
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD3cXhvVGqu74%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10592173
      </pub-id>
      <pub-id pub-id-type="pmcid">
       102409
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/nar/28.1.27
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR81">
     <label>
      81.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kim
        </surname>
        <given-names>
         B-R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Deciphering diversity indices for a better understanding of microbial communities
      </article-title>
      <source>
       J. Microbiol Biotechnol.
      </source>
      <year>
       2017
      </year>
      <volume>
       27
      </volume>
      <fpage>
       2089
      </fpage>
      <lpage>
       2093
      </lpage>
      <pub-id pub-id-type="pmid">
       29032640
      </pub-id>
      <pub-id pub-id-type="doi">
       10.4014/jmb.1709.09027
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR82">
     <label>
      82.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gacesa
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Environmental factors shaping the gut microbiome in a Dutch population
      </article-title>
      <source>
       Nature
      </source>
      <year>
       2022
      </year>
      <volume>
       604
      </volume>
      <fpage>
       732
      </fpage>
      <lpage>
       739
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2022Natur.604..732G
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XpvV2iu7k%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       35418674
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41586-022-04567-7
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR83">
     <label>
      83.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sahu
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Prasuna
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Twin studies: a unique epidemiological tool
      </article-title>
      <source>
       Indian J. Commun. Med.
      </source>
      <year>
       2016
      </year>
      <volume>
       41
      </volume>
      <fpage>
       177
      </fpage>
      <pub-id pub-id-type="doi">
       10.4103/0970-0218.183593
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR84">
     <label>
      84.
     </label>
     <mixed-citation publication-type="other">
      StataCorp. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC. (2019).
     </mixed-citation>
    </ref>
    <ref id="CR85">
     <label>
      85.
     </label>
     <mixed-citation publication-type="other">
      RStudio Team &amp; RStudio: Integrated Development for R.
      <italic>
       RStudio
      </italic>
      . (RStudio, Inc., Boston, MA, 2015).
     </mixed-citation>
    </ref>
    <ref id="CR86">
     <label>
      86.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Black
        </surname>
        <given-names>
         AE
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The sensitivity and specificity of the Goldberg cut-off for EI:BMR for identifying diet reports of poor validity
      </article-title>
      <source>
       Eur. J. Clin. Nutr.
      </source>
      <year>
       2000
      </year>
      <volume>
       54
      </volume>
      <fpage>
       395
      </fpage>
      <lpage>
       404
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BD3c3osVWjuw%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10822286
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/sj.ejcn.1600971
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR87">
     <label>
      87.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Black
        </surname>
        <given-names>
         AE
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Critical evaluation of energy intake using the Goldberg cut-off for energy intake:basal metabolic rate. A practical guide to its calculation, use and limitations
      </article-title>
      <source>
       Int. J. Obes.
      </source>
      <year>
       2000
      </year>
      <volume>
       24
      </volume>
      <fpage>
       1119
      </fpage>
      <lpage>
       1130
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BD3cvosFehsg%3D%3D
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/sj.ijo.0801376
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR88">
     <label>
      88.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <collab>
        Dietary reference values for food energy and nutrients for the United Kingdom.
       </collab>
      </person-group>
      <article-title xml:lang="en">
       Report of the panel on dietary reference values of the committee on medical aspects of food policy
      </article-title>
      <source>
       Rep. Health Soc. Subj. (Lond.)
      </source>
      <year>
       1991
      </year>
      <volume>
       41
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       210
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR89">
     <label>
      89.
     </label>
     <mixed-citation publication-type="other">
      Oksanen, J. et al. vegan: Community Ecology Package [R package version 2.6-4].
      <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=vegan">
       https://cran.r-project.org/package=vegan
      </ext-link>
      (2022).
     </mixed-citation>
    </ref>
    <ref id="CR90">
     <label>
      90.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Holst
        </surname>
        <given-names>
         KK
        </given-names>
       </name>
       <name>
        <surname>
         Scheike
        </surname>
        <given-names>
         TH
        </given-names>
       </name>
       <name>
        <surname>
         Hjelmborg
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The liability threshold model for censored twin data
      </article-title>
      <source>
       Comput. Stat. Data Anal.
      </source>
      <year>
       2016
      </year>
      <volume>
       93
      </volume>
      <fpage>
       324
      </fpage>
      <lpage>
       335
      </lpage>
      <pub-id assigning-authority="American Mathematical Society" pub-id-type="other">
       3406215
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.csda.2015.01.014
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR91">
     <label>
      91.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Scheike
        </surname>
        <given-names>
         TH
        </given-names>
       </name>
       <name>
        <surname>
         Holst
        </surname>
        <given-names>
         KK
        </given-names>
       </name>
       <name>
        <surname>
         Hjelmborg
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Estimating heritability for cause specific mortality based on twin studies
      </article-title>
      <source>
       Lifetime Data Anal.
      </source>
      <year>
       2014
      </year>
      <volume>
       20
      </volume>
      <fpage>
       210
      </fpage>
      <lpage>
       233
      </lpage>
      <pub-id assigning-authority="American Mathematical Society" pub-id-type="other">
       3181012
      </pub-id>
      <pub-id pub-id-type="pmid">
       23378036
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s10985-013-9244-x
      </pub-id>
     </mixed-citation>
    </ref>
   </ref-list>
  </ref-list>
  <app-group>
   <app id="App1" specific-use="web-only">
    <sec id="Sec25">
     <title>
      Taarifa za ziada
     </title>
     <p id="Par73">
      <supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM1_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Supplementary Information
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM2" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM2_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Peer Review File
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM3" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM3_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Reporting Summary
         </p>
        </caption>
       </media>
      </supplementary-material>
     </p>
    </sec>
   </app>
  </app-group>
  <notes notes-type="ESMHint">
   <title>
    Taarifa za ziada
   </title>
   <p>
    The online version contains supplementary material available at
    <ext-link ext-link-type="doi" xlink:href="10.1038/s41467-024-46116-y">
     https://doi.org/10.1038/s41467-024-46116-y
    </ext-link>
    .
   </p>
  </notes>
  <notes notes-type="Misc">
   <p>
    <bold>
     Publisher’s note
    </bold>
    Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
   </p>
  </notes>
 </back>
</article>
